Influences of environmental microbes on the regulation of the human immune system in the context of allergies: from epidemiology to molecular mechanisms by Frei, Remo
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2007
Influences of environmental microbes on the regulation of the human
immune system in the context of allergies: from epidemiology to molecular
mechanisms
Frei, Remo
Abstract: Die Hygiene-Hypothese stellt den Zusammenhang zwischen dem vermehrten Auftreten von Al-
lergien und den verbesserten Hygienebedingungen in der westlichen Welt her. Insbesondere Bauernkinder,
in deren Lebensräumen mehr Mikroben vorkommen, leiden weniger an Allergien. Diese Arbeit zeigt, dass
bisher vorgeschlagene immunologische Mechanismen, wie eine Veränderung in der T Helfer Zell Antwort,
für den Schutz von Bauernkindern vor Allergien nicht relevant sind. Hingegen beobachteten wir, dass
frühkindliche Exposition gegenüber Mikroben Regulationsmechanismen des angeborenen Immunsystems
aktiviert. Diese reduzieren die Entzündungsantwort und die IgE Produktion von Blutzellen der Kinder
und schützen sie so vor dem Auftreten allergischer Symptome. Weiter wurde entdeckt, dass MHC Klasse
II Moleküle eine regulatorische Funktion im angeborenen Immunsystem besitzen. The hygiene hypothe-
sis proposes that the increasing incidence of allergies in western countries is based on improved hygienic
conditions. Especially farmers’ children, living in an environment containing high amounts of microbes,
suffer less from allergies. This work shows that so far proposed immunological mechanisms underlying the
hygiene hypothesis, such as altered T helper cell responses, are not relevant for the protection of farmers’
children against allergies. By contrast, we observed that exposure of children in early life to microbes
induces regulatory mechanisms of the innate immune system. These mechanisms reduce the inflamma-
tory response and the IgE production of blood cells of children and protect them thereby against the
development of allergic symptoms. Furthermore, a novel function of MHC class II molecules as regulators
of the innate immune system was discovered.
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-163567
Dissertation
Published Version
Originally published at:
Frei, Remo. Influences of environmental microbes on the regulation of the human immune system in the
context of allergies: from epidemiology to molecular mechanisms. 2007, University of Zurich, Faculty of
Science.
Influences of Environmental Microbes on the Regulation 
of the Human Immune System in the Context of Allergies: 
From Epidemiology to Molecular Mechanisms 
 
 
 
Dissertation 
zur 
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.) 
 
 
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät 
der 
Universität Zürich 
 
 
 
 
von 
 
Remo FREI 
von 
Widnau SG 
 
 
 
 
Promotionskomitee 
Prof. Dr. Ruedi Aebersold (Vorsitz) 
PD Dr. Roger P. Lauener (Leitung der Dissertation) 
 
 
 
 
Zürich, 2007
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Die vorliegende Arbeit wurde von der Mathematisch-naturwissenschaftlichen Fakultät der Universität 
Zürich im Sommersemester 2007 als Dissertation angenommen. Promotionskommitee: Prof. Dr. 
Ruedi Aebersold (Vorsitz), PD Dr. Roger P. Lauener (Leitung der Dissertation) 
 
 i 
Table of content 
 Zusammenfassung……………………………………………………... iii 
 Summary………………………………………………………………. v 
CHAPTER 1:  Introduction……………………………………………………………. 1 
CHAPTER 2:  Markers of the innate immune system but not of T helper cell 
phenotypes are associated with protection of farmers’ children against 
allergies………………………………………………………………... 37 
CHAPTER 3:  Suppressor of cytokine signaling (SOCS)-1: a link between 
environmental exposure to microbial components and inflammatory 
responses and IgE……………………………………………………… 51 
CHAPTER 4:  Exposure to environmental microbes down-regulates ST2 expression 
in children and thereby protects them against 
allergies………………………………………………………………... 59 
CHAPTER 5: MHC class II molecules enhance Toll-like receptor 2-mediated innate 
immune responses……………………………………………………... 69 
CHAPTER 6: Prenatal farm exposure is related to the expression of receptors of the 
innate immunity and to atopic sensitization in school-age children…... 79 
CHAPTER 7: Early-life exposure to microbial components induces persistent 
modulations of the innate immune system in mice……………………. 95 
CHAPTER 8: Discussion and outlook………………………………………………... 105 
 Abbreviations………………………………………………………….. 111 
 Acknowledgements……………………………………………………. 114 
 Curriculum vitae……………………………………………………….. 115 
 ii 
 iii 
Zusammenfassung 
In den vergangenen Jahrzehnten haben die Fälle der am häufigsten vorkommenden 
Allergie, der IgE-vermittelten Hypersensitivität, zugenommen, so dass heute schon mehr als 
25% der Schulkinder westlicher Länder darunter leiden. Eine Allegie wird ausgelöst, wenn 
eine B Zelle als Antwort auf Proteine aus der Umgebung IgE anstatt IgG sezerniert. Die 
Entstehung von allergischen Erkrankungen ist prinzipiell genetisch bedingt. Beobachtungen, 
dass Infektionenen oder Exposition gegenüber verschiedenen Umweltfaktoren wie Mikroben 
oder Diätfaktoren Kinder vor Allergien schützen, führten zur Formulierung der Hygiene-
Hypothese. Diese Hypothese sagt, dass verminderte Exposition gegenüber infektiösen 
Substanzen während der frühen Kindheit zu abweichenden Immunantworten gegen harmlose 
Antigene im späteren Leben führt. 
Das Ziel dieser Arbeit war zu untersuchen, wie Mikroben in der Umwelt das Immunsystem 
von Kindern beeinflusst, so dass sie vor Allergien geschützt sind. Wir verglichen die 
Expression von relevanten Markergenen des Immunsystems und untersuchten die 
Reaktionsfreudigkeit von Blutzellen von Bauern- und Nichtbauernkinder im Rahmen der 
Europäischen Querschnittsstudien ALEX und PARSIFAL. Im ersten Teil dieser Arbeit 
untersuchten wir, ob zwei oftmals vorgeschlagene immunologische Mechanismen für die 
Hygiene-Hypothese seine Relevanz auch für Bauernkinder hat. Beide Mechanismen, 
verschobenes Th-1/Th-2 Gleichgewicht, das den Immunoglobulin Klassenwechsel kontrolliert 
und die Bildung von regulativen T Zellen, konnten in unserem System nicht reproduziert 
werden. 
Weil das angeborene Immunsystem die erste Verteidigungslinie gegen fremde Moleküle 
bildet und die Immunglobulin-vermittelte adaptive Immunantwort durch lösliche Faktoren 
steuert, vermuteten wir hier die Molekulare Grundlage für die Hygiene-Hypothese. Wir 
fanden, dass die Expression von Markergenen des angeborenen Immunsystems negativ mit 
dem Immunglobulin Klassenwechsel zu IgE assoziert war. Die Signalkaskade von Toll-like 
Rezeptoren, den wichtigsten Erkennungsrezeptoren des angeborenen Immunsystems, ist sehr 
genau reguliert, weil fehlerhafte Aktivierung zu Krankheiten wie Allergien und 
Autoimmunität führen könnte. Wir fanden, dass die Expression vom regulatorischen Molekül 
„Suppressor of cytokine signaling 1“ durch die Expostion gegenüber Mikroben in der Umwelt 
induziert wird und dass es so Kinder vor Allergien schützt. Aber nicht alle regulatorischen 
Moleküle der Signalkaskade von Toll-like Rezeptoren hatten dieselbe Relevanz in Kindern. 
Wir konnten diese Funktion nicht reproduzieren für ST2. Vielmehr schützte ST2 die Kinder 
gegen Allergien durch Regulation der T Helferzellaktivität. 
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Dann beschrieben wir MHC Klasse II Moleküle als neue Beteiligte im regulatorischen 
Netzwerk des angeborenen Immunsystems. Allerdings sind weiterführende Studien nötig um 
abzuklären, ob MHC Klasse II Moleküle auch am Schutz von Bauernkindern gegen Allergien 
beteiligt sind. 
Schliesslich untersuchten wir, bei welchem Alter die Exposition gegenüber Mikroben in 
der Umwelt den grössten Schutz vor Allergien bringt und wie langer er anhält. Wir fanden 
heraus, dass vorgeburtliche Exposition den effektivsten Schutz vor Allergien bringt. 
Vorgeburtliche Exposition verändert die Expression von Markergenen des angeborenen 
Immunsystems anhaltend in Kindern und Mäusen. Es scheint, dass frühkindliche Exposition 
gegen Mirkroben bestimmt, wie das angeborene Immunsystem die Immunoglobulin-
vermittelte adaptive Immunantwort im späteren Leben aktivert. Diese Veränderungen 
scheinen ausschlaggebend für den Schutz gegen allergische Erkrankungen zu sein. 
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Summary 
The incidence of the most common form of allergy, the IgE-mediated hypersensitivity, has 
increased over the past decades and affects already more than 25% of school-age children of 
western countries. An allergy manifests through secretion of IgE instead of IgG by B cells in 
response to environmental proteins. The development of allergic disorders is principally 
regulated by genetic factors. Observations that infections or exposure to various 
environmental factors such as microbes or dietary factors protect children against the 
development of allergies, led to proposition of the hygiene hypothesis. This hypothesis states 
that decreased exposure to infectious agents early in life results in aberrant immune responses 
to otherwise innocuous antigens later in life. 
The aim of this work was to investigate how exposure to environmental microbes 
influences children’s immune system resulting in protection against allergies. We compared 
gene expression of relevant marker genes of the immune system and assessed responsiveness 
of blood cells of farmers’ and non-farmers’ children in the context of the European cross-
sectional ALEX and PARSIFAL studies. In the first part of this work we investigated whether 
two often proposed immunological mechanisms for the hygiene hypothesis have relevance in 
farmers’ children. Both mechanisms, a skewing of the Th-1/Th-2 balance controlling 
immunoglobulin class switching and the generation of T regulatory cells, could not be 
reproduced in our system. 
Since the innate immune system constitutes the first contact to foreign molecules and 
directs the immunoglobulin-mediated adaptive immune response through release of soluble 
factors, we assumed here the molecular basis of the hygiene hypothesis. We found that the 
expression of marker genes of the innate immune system was negatively associated with 
immunoglobulin isotype switching to IgE. These marker genes, in turn, were induced through 
exposure to environmental microbes in children. Furthermore, the signaling cascade of Toll-
like receptors, the primary pattern recognition receptors of the innate immune system, is 
tightly regulated, because miss-activation may lead to diseases such us allergy and 
autoimmunity. We found that the expression of the regulatory molecule suppressor of 
cytokine signaling 1 was controlled by environmental exposure to microbes and thereby 
protect children against the development of allergies. But not all of these regulatory molecules 
of the signaling cascade of Toll-like receptors had the same relevance in children. We failed 
the reproduce a regulatory function for ST2. By contrast, ST2 protected children against 
allergies via regulation of T helper cell activity. 
Then, we identified MHC class II molecules as novel participant in the regulatory network 
of the innate immune response. Whether these molecules are involved in protecting children 
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living in environments containing higher amounts of microbes against allergies, has to be 
investigated in future studies. 
Finally, we investigated the optimal age of exposure to microbial components to reach 
highest protection against allergies and how long it persists. It turned out, that prenatal 
exposure to microbes led to most effective protection of children against the disorders. 
Furthermore, prenatal exposure induced persistent modulation of the expression of marker 
genes of the innate immune system in children and in mice. Therefore, early-life exposure to 
microbial components shapes the way, how the innate immune system activates the 
immunoglobulin-mediated adaptive immune response in the later life. These modulations 
seem to be crucial to develop protection against allergic diseases. 
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Chapter Overview 
This chapter gives an introduction in the epidemiology of IgE mediated allergic diseases 
and its increasing incidence in the past decades in western countries. Then, there is an 
introduction to the two arms of the immune system: the innate and the adaptive immunity. 
The tightly regulated innate immune system constitutes the first contact to foreign patterns 
and induces the B and T cell mediated adaptive immune system. Of the adaptive immunity, 
the T helper cell differentiation and the regulation of immunoglobulin class switching to IgE 
is considered profoundly. In the last part, an overview about the objectives of this study is 
given. 
1. Epidemiology of allergic diseases 
The development of allergic diseases is basically influenced by genetic factors1. Findings 
of regional variation in incidence of symptoms of asthma, allergic rhinoconjunctivitis, and 
atopic eczema in school-age children with the same genetic background made environmental 
components likely to be involved in the development of these diseases, too2. Children in 
developed countries like England or New Zeeland had about a 20 times higher prevalence of 
asthma symptoms than children of developing countries like Indonesia or Albania. 
The incidence of allergic diseases was not always higher in western countries. The 
prevalence of asthma e.g. increased by 75% from 1980 to 1994 in the USA3. In Swedish 
schoolchildren the prevalence of asthma, hay fever, and atopic eczema doubled between 1979 
and 19914. Also other inflammatory diseases like Crohn’s disease or autoimmunity have 
increased in developed countries. During the same period of time the incidence of infectious 
diseases like Hepatitis A, Mumps, or Tuberculosis has decreased in these countries4-6. 
2. The hygiene hypothesis 
The term hygiene hypothesis has emerged to describe the correlation between the increase 
in hygienic conditions and the elevation especially in allergic disorders. The hygiene 
hypothesis was proposed after a lower risk of hay fever and atopic sensitization in children 
with more siblings was observed7. The protective effect was assigned to elevated infections 
during childhood. Other findings supported this hypothesis: early entry to day care of the 
children had a protective effect against the development of allergies8 and Italian military 
students with antibodies to hepatitis A virus had a lower prevalence of atopy and atopic 
respiratory diseases9. 
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Other studies showed that not only infections protected children against allergies, but also 
rural lifestyle10. Specially contact to farm animals seemed to be highly protective11, 12. The 
protective effect of the farm was assigned to exposure to higher loads of bacterial components 
as shown for endotoxin, a lipopolysaccharide of the outer layer of the cell membrane of 
Gram-negative bacteria13, 14. Furthermore, drinking of non-pasteurized milk or exposure of the 
mother to stable and stable animals during pregnancy had a protective effect on the children15. 
3. The ALEX and PARSIFAL studies 
The goal of the international cross-sectional epidemiological studies ALEX (Allergy and 
Endotoxin)16 and PARSIFAL (Prevention of Allergy Risk factors for Sensitization In children 
related to Farming and Anthroposophic Lifestyle)17 was to identify factors related to farm live 
and conferring protection of children against allergies and to identify the underlying 
immunological mechanisms. In the ALEX study, the bacterial cell wall component endotoxin 
was observed to correlate with protection of children against the development of allergies13. 
Maternal exposure to stable and stable animals during pregnancy were the most protective 
factors of the children of the PARSIFAL study (Chapter 6)15. Therefore, early life exposure to 
bacterial components seems to be important for providing effective protection. Furthermore, 
children spend blood to assess molecular mechanisms that are induced through exposure to 
microbial components and conferring protection against allergic diseases, i.e. constituting the 
immunological basis of the hygiene hypothesis. We assessed the expression of marker genes 
of the immune system in blood leukocytes and the responsiveness of these cells, the genetic 
background, and the immunoglobulin levels in serum of the children. 
4. The immune system 
The human immune system recognizes and eliminates invading microorganisms in two 
ways. The adaptive or acquired immunity, consisting of B and T cells, uses a vast set of 
antibodies and T cell receptors generated through gene rearrangement and somatic 
hypermutation with a high specificity against any foreign pattern or peptide. An organism 
needs 7 to 10 days to establish a fully running adaptive immune response. The highly 
effective acquired immunity is responsible for elimination of infection in a late phase and for 
the establishment of immunological memory. By contrast, the evolutionary conserved innate 
immunity constitutes the first line defense of a host to survive the early phase of infection. 
Furthermore, innate immunity provides co-stimulatory molecules and cytokines to direct the 
adaptive immune response. The innate immune system recognizes only a limited number of 
conserved structures of invading microorganisms through a limited number of germ-line 
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encoded pattern recognition receptors (PRR) and it seems to be independent of immunologic 
memory18, 19. 
4.1 The innate immune system 
4.1.1 Pattern recognition receptors 
Toll-like receptors 
The Toll receptor was initially discovered in Drosophila. It is an evolutionary conserved 
receptor found in the worm Caenorhabditis elegans as well as in mammalians18. The immune 
system of the fruit fly is lacking an adaptive system making the Toll protein a central 
regulator of the immune defense. The signaling pathway of the receptor is a homologue to the 
one of the human innate immune system. It activates a NF-κB related transcription factor and 
induces production of antimicrobial peptides similar to the mammalian defensin family20, 21. 
In mammalian, 12 homologue forms of the Toll receptor are described and called Toll-like 
receptors (TLR), constituting the principal family of PRR in mammals. Humans have 10 
functional TLR while TLR11 is non-functional due to a stop codon in the gene. Human 
TLR12 has not been documented so far. TLR are type I transmembrane glycoproteins22. The 
extracellular domain is composed of leucin-rich repeats (LRR), shaped as horseshoe structure 
and responsible for ligand binding23. The cytoplasmatic domain is homologous to that of the 
interleukin 1 receptor and termed Toll/IL-1R homology (TIR) domain24. 
TLR are mainly expressed on cells of the immune system such as macrophages, dendritic 
cells (DC), mast cells, B cells and some T-cells. Some TLR are found in endothelial cells, 
fibroblasts, adipocytes, and epithelial cells, too25, 26. The expression of TLR is not static but 
modulated in response to pathogens, cytokines, or environmental exposure to microbial 
components27. In chapter 6 and 7, we describe that especially exposure to microbial 
components in early life leads to persistent induction of TLR expression. Not all TLR are 
expressed extracellulary in the plasma membrane. TLR3, 7, 8, and 9 are found almost 
exclusively expressed in the endosomal compartments. 
Based on their amino acid sequence, human TLR can be divided into five subgroups, each 
recognizing related structures28, 29. The ligand recognition concept of TLR is completely 
different to that of antibodies or T cell receptors generating a binding domain against almost 
any imaginable foreign structure. TLR rather recognize conserved molecules of 
microorganisms called pathogen-associated molecular patterns (PAMP). 
 5 
TLR1, 2, 6, and 10. The TLR2 subfamily is composed of TLR1, 2, 6 and 10. This 
subgroup recognizes lipids of many different microorganisms (Table 1). TLR1 and 6 act as 
co-receptors of TLR2 recognizing lipoproteins of bacteria, mycoplasma, and mycobacteria30-
32. TLR2 alone recognizes peptidoglycan and lipoteichoic acid from Gram-positive bacteria or 
lipoarabinomannan of mycobacteria (Figure 1). Together with the co-receptor dectin, TLR2 
recognices zymosan from fungi18, 28, 33. The ligands of TLR10 are unknown. 
TLR4. TLR4 is the TLR investigated in most detail. It recognizes lipopolysaccharides 
(LPS or endotoxin), an integral part of the outer cell membrane of Gram-negative bacteria 
(Table 1). LPS consists of an intracellular lipid A component and an extracellular 
oligosaccharide34 (Figure 1). Even in picomolar range, LPS induces a strong inflammatory 
response in leukocytes, but also in platelets, endothelial cells, and epithelial cells35, whereas 
the lipid A portion is the part carrying most biological activity. A single Escherichia coli cell 
contains about two millions LPS molecules. They are released upon cell death and during 
growth and division. In humans LPS is responsible, when entering the blood stream, for fever, 
hypotension, adult respiratory distress syndrome, disseminated intravascular coagulation, and 
endotoxin shock. By contrast, its presence in a low dose in the environment of children has 
been associated with protection against the development of allergies13. LPS is highly heat-
stable; therefore a temperature of over 180°C is necessary to inactivate it34. Bacteria produce 
different LPS molecules. They vary in their phosphate patterns, number of acylchains, and 
fatty-acid composition reflecting the varied biological activities of different lipid A 
molecules, resulting in altered toxicity18. 
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FIGURE 1. Overview of bacterial cell walls. A, The cell wall of Gram-positive bacteria consists of a 
thick layer of peptidoglycan. Lipoteichoic acids and lipoproteins are embedded in this cell wall. B, 
The cell wall of Gram-negative bacteria is characterized by a second lipid bilayer containing large 
amounts of LPS. C, Mycobacteria have a thick hydrophobic layer containing mycolyl arabinogalactan 
and dimycolate. Lipoarabinomannan is a major cell wall associated glycolipid. D, LPS is composed of 
the biological active lipid A (endotoxin), core oligosaccharide, and O-antigen. LPS, lipopolysaccaride; 
LAM, Lipoarabinomannan. (Adapted from Akira et al., Cell. 2006 Feb 24, 124 (4): 783-801 and from 
Miller et al., Nat Rev Microbiol. 2005 Jan, 3 (1): 36-46) 
LPS binds to the LPS binding protein (LBP), an acute-phase protein present in serum. This 
complex binds to CD14, which exists in two forms. The soluble form (sCD14) is present in 
the blood plasma and the membrane bound form (mCD14) is attached to phagocyte 
membranes through a glycosylphosphatidylinositol (GPI) anchor. SCD14 enables stimulation 
of cells lacking the membrane bound form. LPS is transferred by soluble factor MD-2 to 
TLR4 leading to cell activation18, 34, 36. Other factors such as heat shock proteins (Hsp) 70 and 
90, chemokine receptor (CXCR) 4, growth differentiation factor 5, CD11b, CD18, and CD55 
are described to be involved in the LPS binding and cell activation complex28, 37, 38. 
Besides of LPS, TLR4 recognizes peptides, too. Examples are taxol from the Pacific yew 
having a potent anti-tumor activity in humans or endogenous ligands like Hsp 60 and 70. Heat 
shock proteins are induced in response to stressful condition or infection. It is thought that 
heat shock proteins activating macrophages and dendritic cells act as endogenous danger 
signal28. 
TLR5. TLR5 recognizes flagellin, the primary protein component of flagella (Table 1). 
Gram-negative bacteria use flagella as propellers to move through aqueous environment. 
Furthermore, flagella aid bacteria to attach to host cells and contribute thereby to the virulence 
of pathogenic bacteria28. 
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TLR3. Double stranded (ds) RNA is produced by viruses. It is recognized by TLR3 and 
serves as potent inducer of type I interferons (INF-α and β), which have antiviral and 
immuno-stimulatory activities (Table 1). TLR3 is expressed on conventional DC and in a 
variety of epithelial cells functioning as barriers to infections. Another receptor for dsRNA is 
the dsRNA-dependent protein kinase (PKR) having immuno-stimulatory effects, too18, 28. 
TLR7, 8, and 9. Single stranded (ss) RNA is recognized by TLR7 and 839, 40. Both genes 
are homolog to the TLR9 gene. TLR9 recognizes unmethylated CpG DNA, which is common 
in viral and bacterial genomes, but rare in vertebrate18, 28 (Table 1). 
Table 1. Toll-like receptors and their ligands
TLR Ligands Origin
TLR1 Tri-acyl lipopeptides Bacteria, mycobacteria
TLR2 Lipoproteins Bacteria, mycoplasma, mycobacteria
Peptidoglycan Gram-positive bacteria
Lipoteichoic acid Gram-positive bacteria
Lipoarabinomannan Mycobacteria
Phenol-soluble modulin Staphylococcus epidermidis
Glycoinositolphospholipoids Trypanosoma Cruzi
Glycolipids Treponema maltophilum
Porins Neisseria
Atypical LPS Leptospira interrogans
Atypical LPS Porphyromans gingivalis
Zymosan Fungi
Heat-shock protein 70 Host
TLR6 Di-acyl lipopeptides Mycoplasma
Lipoteichoic acid Gram-positive bacteria
Zymosan Fungi
TLR4 LPS Gram-negative bacteria
Taxol Plants
Fusion protein Respiratory syncytial virus
Envelope protein Mouse mammary-tumour virus
Heat-shock protein 60 Chlamydia pneumoniae
Heat-shock protein 60 Host
Heat-shock protein 70 Host
Type II repeat extra domain A of fibronectin Host
Oligosaccharides of hyaluronic acid Host
Polysaccharide fragments of heparan sulfate Host
Fibrinogen Host
TLR5 Flagellin Bacteria
TLR3 Double stranded RNA Virus
TLR7 Imidazoquinoline Synthetic compounds
Loxoribine Synthetic compounds
Bropirimine Synthetic compounds
Single stranded RNA Virus
TLR8 Imidazoquinoline Synthetic compounds
Single stranded RNA Virus
TLR9 CpG DNA Bacteria, virus
Adapted from Takeda et al, Annu Rev Immunol 21, 335-76 (2003)
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Other receptors of the innate immunity 
NOD. Nucleotide-binding oligomerization domain (NOD) proteins are a family of 20 
cytosolic molecules possessing a LRR domain for ligand recognition as well as caspase 
activation and recruitment domain (CARD) for induction of the downstream signaling 
cascade. NOD proteins act thereby as cytosolic PRR. Only ligands of NOD1 and NOD2 are 
known. They detect γ-D-glutamyl dipeptide and muramyl dipeptide found in bacterial 
peptidogycans. Binding of ligands to NOD1 and NOD2 causes their oligomerization and 
results in activation of NF-κB and of receptor-interacting protein (RIP) 2 kinase leading to 
release of inflammatory cytokines18, 41. Mutations in the NOD2 gene are associated with 
Crohn’s disease, an inflammatory bowel disease associated with enhanced NF-κB activity and 
T helper cell type 1 response42, 43. 
TREM. Triggering receptors expressed by myeloid cells (TREM)1 and TREM2 are 
transmembrane glycoproteins consisting of a single extracellular immunoglobulin-like 
domain, a transmembrane region with charged lysine residues, and a short cytoplasmatic tail. 
Both receptors associate with DAP12 for signaling and function. DAP12 contains an 
immunoreceptor tyrosine-based activation motif (ITAM), which after phosphorylation, 
recruits tyrosine kinases ζ-chain-associated protein 70 (ZAP70) and spleen tyrosine kinase 
(SYK). The signaling cascade ends in the activation of phosphatidylinositol 3-kinase (PI3K), 
phospholipase Cγ1, and p44-p42 extracellular-signal-regulated kinase (ERK). Triggering of 
this pathway leads to Ca2+ release, rearrangement of the actin cytoskeleton, and activation of 
transcriptional complexes. Human TREM1 is expressed by blood neutrophils, monocytes, and 
macrophages. The expression is induced in neutrophils and epithelial cells during an infection 
with bacteria or fungi. TREM1 amplifies TLR-initiated inflammatory responses to microbial 
challenges. Although the ligand of TREM1 is unknown, it is clear that TREM1 has an 
important role in establishing inflammation and endtoxin shock44, 45. Human TREM2 is 
expressed by immature DC. After activation, DC down-regulate the expression of TREM2. 
TREM2 seems to be involved in DC maturation as well as in the maturation of the non-
immunological osteaclasts, microglia, and oligodendrocytes45. 
RIG-I and Mda5. Retinoic-acid-inducible protein (RIG)-I and melanoma differentiation 
associated gene (Mda) 5 are cytosolic RNA helicases carrying 2 caspase activation and 
recruitment domain (CARD)-like domains. The RNA helicases recognize viral dsRNA and 
the CARD-like domains are responsible for activation of downstream signaling pathways 
leading to activation of transcription factors NF-κB and interferon regulatory factor (IRF)-3, 
thereby inducing inflammatory cytokines and type I IFNs18, 29, 46. 
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4.1.2 TLR signaling pathway 
After ligand binding, TLR dimerize and undergo conformational changes. This enables the 
recruitment of TIR-domain containing adaptor molecules to the TIR domain of the TLR. 
There are five such adaptor molecules known: Myeloid differentiation primary-response 
protein 88 (MyD88), TIR-associated protein (TIRAP/MAL), TIR-domain-containing adaptor 
protein-inducing IFN-β (TRIF/TICAM1), TRIF-related adaptor molecule (TRAM), and steril 
α and armadillo motifs (SARM). Alternative usage of these adaptor molecules by TLR 
explains the differing responses induced by different TLR ligands18, 42, 47. SARM negatively 
regulates adaptor protein TRIF dependent TLR signaling48. 
MyD88 dependent signaling pathway 
The MyD88 dependent signaling pathway is homologous to the one of the IL-1 receptor. 
MyD88 has a C-terminal TIR domain, which associates with the TIR domain of TLR after 
ligand binding, and an N-terminal death domain. TLR2 and TLR4 require another adaptor 
protein, TIRAP, for MyD88 recruitment. The IL-1R-associated kinase (IRAK)-4 is recruited 
to MyD88 via dimerization of the death domains of the molecules. IRAK-4 then activates 
IRAK-1 through phosphorylation. IRAK-1 subsequently associates with TNFR-associated 
factor (TRAF) 6 an ubiquitin protein ligase E3. TRAF6 catalyses polyubiquitination of itself 
and of NEMO (IKK-γ/NF-κB essential modulator) supported by the E2 ubiquitin ligase 
complex composed of UBC13 and UEV1A. Another complex composed of TGF-β-activated 
kinase 1 (TAK1) and TAK1 binding proteins (TAB) 1-3 is recruited to TRAF6, too. TAK1 
activates two different signaling ways, the MAP kinase cascade leading to activation of the 
AP-1 complex (p38 kinase and Jun N-terminal kinase (JNK)) and the activation of the IκB 
kinase (IKK) complex including NEMO, IKK-γ,  IKK-α, and IKK-β. Activated IKK complex 
induces phosphorylation and ubiquitination of IκB ending in its degradation by the 
proteosome. Liberated transcription factor NF-κB and AP-1 complex translocate to the 
nucleus to induce transcription of inflammatory genes18, 42. The transcription factor IRF-5 is 
also activated by TRAF6 and is responsible for induction of cytokine genes49 (Figure 2). 
TRIF dependent signaling pathway 
TLR3 and TLR4 have the ability to induce type I IFN (IFN-α and IFN-β) in a MyD88 
independent way. Instead of MyD88, the adaptor TRIF is recruited to the receptor after ligand 
binding. TLR4 needs support of TRAM to bind TRIF. TRIF interacts with the receptor-
interacting protein 1 (RIP1), which activates NF-κB but with delayed kinetics compared to 
the MyD88 dependent way50. Furthermore, TRIF activates TRAF-family-member-associated 
NF-κB activator (TANK) binding kinase 1 (TBK1) leading to phosphorylation and 
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translocation of the transcription factors IRF-3 and IRF-7, responsible for induction of IFN-
inducible genes. TLR7 and TLR9 ligands are also able to induce type I IFN production in a 
TRIF independent, but MyD88 dependent way18, 42 (Figure 2). 
 
FIGURE 2. Toll-like receptor signaling cascade. MyD88 dependent pathway: MyD88 is recruited to 
the receptor after ligand binding. Then, MyD88 binds the kinase IRAK-4, which activates IRAK-1. 
IRAK-1 associates with TRAF6, which is responsible for polyubiquitination of NEMO and activation 
of the complex of TAK1 and TAB1-3 leading to translocation of NF-κB into the nucleus and to 
activation of MAP kinase. TRIF dependent pathway: TLR3 and TLR4 have the ability to recruit TRIF 
to the receptor after ligand binding. TRIF interacts with RIP1 leading to NF-κB translocation and with 
TBK1 inducing translocation of transcription factors IRF-3 and IRF-7 into the nucleus ending in 
induction of type I IFN. MyD88, myeloid differentiation primary-response protein 88; IRAK, IL-1R-
associated kinase; TRAF6, TNFR-associated factor 6; NEMO, IKK-γ/NF-κB essential modulator; 
TAK1, TGF-β-activated kinase 1; TAB, TAK1 binding proteins; TRIF, TIR-domain-containing 
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adaptor protein-inducing IFN-β; RIP, receptor-interacting protein; IFN, interferon. (Adapted from 
Liew et al., Nat Rev Immunol. 2005 Jun, 5 (6): 446-58) 
4.1.3 Regulators of the TLR signaling cascade 
Activation of the TLR signaling cascade is absolutely necessary to establish an immune 
response. But the process has to be tightly regulated, because misguided activation of the 
innate immune system may enhance the risk to develop chronic inflammation, allergy, and 
autoimmunity1. 
Repeated challenge with LPS leads to a reduced responsiveness to a subsequent 
stimulation with LPS. This is a well known phenomenon and is designated as endotoxin or 
LPS tolerance42. Many different molecules and mechanisms have been proposed to be 
involved in negative regulation of the TLR signaling cascade. We investigated two of these 
molecules, SOCS-1 and ST2, whether they have regulatory function in children exposed to 
high levels of endotoxin in their environment and whether these molecules may protect them 
against allergic diseases (Chapter 3 and 4). 
Regulation starts in blood and tissues, where soluble TLR interact with ligands, and ends in 
many intracellular regulators controlling the TLR signaling cascade (Figure 3). Regulation 
also occurs through down-regulation of transcription and translation of TLR genes or by 
degradation of TLR protein51. Furthermore, we have identified MHC class II molecules as 
novel participants in the complex regulatory mechanisms that control the efficiency of innate 
immune responses (Chapter 5). 
Soluble TLR. Soluble forms of TLR2 and TLR4 have been found in mammalians. Soluble 
TLR2 has been described in humans, whereas soluble TLR4 has been found in mice. The 
mechanism by which the soluble form attenuates TLR signaling is unknown. However, 
soluble forms of TLR might serve as important first-line negative regulators of innate 
immunity51. 
MyD88s. MyD88s is an alternative splice variant of MyD88 lacking the intermediate 
domain situated between the death domain, which mediates contact to the IRAK family, and 
the TIR domain interacting with TLR. MyD88s is induced by LPS in monocytic cells and 
inhibits LPS-induced NF-κB activation. MyD88s inhibits the ability of IRAK-4 to 
phosphorylate IRAK-1 so that IRAK-4 cannot be recruited to the receptor complex51-53. 
SOCS. The family of suppressor of cytokine signaling (SOCS) proteins is well described 
as key regulator molecule in TLR signaling. The human family consists of seven members54-
56. SOCS-1 and SOCS-3 were originally found to be necessary in suppressing inflammatory 
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responses by acting as negative feedback inhibitor in cytokine signaling pathways by 
inhibiting the JAK kinase activity57-59. Mice lacking SOCS-1 die within 3 weeks because of 
organ damage induced by excessive levels of INF-γ60. At least some of the SOCS proteins 
(SOCS-1 and SOCS-3) are induced through TLR agonists such as LPS or unmethylated CpG 
DNA61, 62. SOCS proteins negatively regulate TLR signaling through induction of degradation 
of TIRAP63. We found that SOCS-1 is up-regulated in children living in an environment rich 
in microbes. Furthermore, expression of SOCS-1, in turn, correlates with decreased secretion 
of the inflammatory cytokine INF-γ and reduced IgE levels (Chapter 3). 
IRAK-M and IRAK-2. The expression of IRAK-M is restricted to monocytes and 
macrophages and it is induced through TLR ligands. IRAK-M has no kinase activity and it 
prevents the dissociation of the IRAK-1 – IRAK-4 complex from MyD88. IRAK-M decreases 
the response to TLR stimuli and is required for endotoxin tolerance51, 52, 64. The IRAK-2 gene 
consists of four splice variants called IRAK-2a-d. IRAK-2c and IRAK-2d are missing the 
death domain. They are induced through LPS and inhibit LPS-induced NF-κB activation51. 
PI3K. PI3K is a heterodimeric protein consisting of a p85 regulatory subunit and a p110 
catalytic part. It is constitutively expressed by most cells and functions as signal in many 
cellular events. P85-deficent mice show enhanced IL-12 production in response to TLR 
ligands, possibly because of increased activation of the p38 kinase51, 52. Other groups found 
that PI3K has a positive role in signaling process as inducer of NF-κB activation65. The 
discrepancy may be due to differences in cell types used. 
TOLLIP. TOLLIP (Toll-interacting protein) interacts in resting, unstimulated cells with 
IRAK-1, thereby preventing NF-κB activation by blocking phosphorylation of IRAK-1. After 
TLR stimulation, the IRAK-1 – TOLLIP complex is recruited to the receptor leading to 
autophosphorylation of IRAK-1 and its dissociation from the receptor. Furthermore, IRAK-1 
phosphorylates TOLLIP ending in its ubiquitylation and degradation. Therefore, TOLLIP 
maintains the immune cell in a quiescent state in absence of stimulation51, 52, 66. 
A20. The expression of A20 is induced by LPS. A20-deficient macrophages produce 
elevated levels of pro-inflammatory cytokines following stimulation of TLR. A20 is a 
cysteine protease deubiquitylating enzyme that blocks TLR signaling by deubiquitylating 
TRAF651. 
TRIAD3A. TRIAD3A is an E3 ubiquitin-protein ligase, down-regulating the protein 
expression of TLR4, TLR9, and to a minor degree of TLR3 and TLR5. Degradation by 
ubiquitination is a general mechanism to regulate protein expression. Covalent attachment of 
ubiquitin to the target protein is a pathway with three enzymes involved. The E1 ubiquitin-
activating protein activates ubiquitin by formation of a thioester bond between ubiquitin and 
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cysteine at the active site of E1. Ubiquitin is then transferred to a second ubiquitin-conjugated 
enzyme (E2) to form a thioester linkage. E3 promotes formation of an isopeptide bond 
between ubiquitin and lysine residues on the target protein ending in degradation of the 
ubiquitinated protein by the proteosome67. 
SHIP. SHIP expression is induced though LPS and mediates increase in TGF-β production 
by macrophages and mast cells. SHIP inhibits PI3K mediated NF-κB activation and is thereby 
essential for endotoxin tolerance68. 
RIP3. RIP3 negatively regulates TRIF signaling by preventing association between RIP1 
and TRIF. Thereby, it inhibits RIP1 mediated NF-κB activation50, 69. 
ST2. ST2 (also known as T1, Fit-1 or DER4) is a type I transmembrane protein with three 
extracellular immunoglobulin-like domains and an intracellular TIR domain70, 71. A soluble 
form of ST2 exists, too. It is generated by alternative splicing and is present in normal human 
serum. ST2-deficient mouse macrophages produce elevated amounts of cytokines after 
stimulation of TLR2, TLR4, and TLR9, but not of TLR3. ST2 achieves its inhibitory effects 
through sequestration of MyD88 and TIRAP72-74. After 4 hours in vitro stimulation with the 
TLR4 stimulus LPS or with inflammatory cytokines, ST2 is slightly induced in macrophages 
or monocytes turning ST2 into a negative feedback inhibitor74, 75. Soluble ST2 is increased in 
serum of patients with inflammatory diseases like asthma but also with autoimmunity, 
indicating an influence of ST2 on T helper cell differentiation76-78. We found that ST2 
expression is decreased in children exposed to microbial components and this, in turn, is 
associated with reduced T helper cell activation, lower IgE levels in serums, and fewer 
incidences of allergic diseases. In children living in areas containing high levels of microbial 
components, ST2 fails to act as negative regulator of the TLR signaling cascade (Chapter 4). 
SIGIRR. SIGIRR is a transmembrane protein with a single extracellular immunoglobulin 
domain and a cytoplasmatic TIR domain. It is expressed on epithelial cells, immature 
dendritic cells, but not on macrophages. Mice lacking SIGIRR have an increased 
susceptibility to endotoxin shock and DC of these mice show an elevated response to TLR4 
and TLR9 ligands. The mechanism by which SIGIRR suppresses TLR function is probably 
via interaction with TLR4, IRAK, and TRAF651, 79. 
TRAILR. TRAILR belongs to the TNF superfamily and is the receptor of TRAIL. 
Stimulation through TLR2, TLR3, and TLR4, but not TLR9 leads to enhanced expression of 
TRAIL and to elevated production of cytokines in TRAILR-deficient macrophages. TRAILR 
seems to inhibit TLR signaling by stabilizing the IκB complex and thereby inhibiting nuclear 
translocation of NF-κB51. 
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RP105. RP105 is a TLR-like molecule, lacking the cytoplasmatic TIR domain. It is 
expressed in B-cells and antigen-presenting cells (APC) and acts as specific inhibitor for 
TLR4 signaling. RP105 forms a complex with MD-1 and directly interacts with the TLR4 – 
MD-2 complex inhibiting the ability of this complex to bind LPS80. 
Apoptosis. Interaction of TLR2 with its ligands can trigger apoptosis in macrophages and 
epithelial cells. The process seems to be dependent on MyD88, FADD (Fas-associated via 
death domain), and caspase-8 inducing the apoptotic cascade. However, the activation of NF-
κB through MyD88 is anti-apoptotic. It is not clear, how positive and negative regulation of 
apoptosis though the same TLR signaling pathway is regulated on cellular levels30, 51. 
 
FIGURE 3. Regulators of Toll-like receptor signaling cascade. A, Transmembrane regulators of TLR 
signaling cascade: ST2 and SIGIRR inhibit MyD88 dependent NF-κB activation through binding to 
MyD88, TIRAP or IRAK. TRAILR supress NF-κB activation in a later stage of the TLR signaling 
cascade. B, Intracellular regulator of TLR signaling cascade: TRIAD3A induces polyubiquitination 
and degradation of certain TLR, while MyD88s antagonizes MyD88 functions. Regulatory molecules 
like SOCS1, IRAK-M, TOLLIP, IRAK2c and IRAK2d selectively suppress TLR signaling on various 
stages. PI3K negatively regulates some TLR responses. A20 deubiquitylates TRAF6 and affects 
MyD88-dependent and MyD88-independent pathways. MyD88, myeloid differentiation primary-
response protein 88; TIRAP, TIR-associated protein; IRAK, IL-1R-associated kinase; MyD88s, short 
form of MyD88; SOCS-1, suppressor of cytokine signaling 1; TOLLIP, toll-interacting protein; PI3K, 
phosphatidylinositol 3-kinase; TRAF6, tumour-necrosis factor-receptor-associated factor 6. (Adapted 
from Liew et al., Nat Rev Immunol. 2005 Jun, 5 (6): 446-58) 
 15 
4.2 Inflammation 
Inflammation is observed in infections, but also in autoimmunity, allergies, atherosclerosis, 
or Alzheimer’s disease. It is characterized by swelling, pain, increase in body temperature, 
tissue injury, and the influx of immunologically active cells. During an inflammatory 
response a variety of mediators are released by cells of the innate and adaptive immune 
systems. These cells are tissue mast cells, blood platelets, neutrophiles, monocytes, 
macrophages, eosinophils, basophils, and lymphocytes. After an infection, the innate 
immunity initiates an inflammatory response with the aim of fighting the invading pathogens 
in the early phase of infection, to attract immune cells to the host of infection, and to activate 
an adaptive immune response. 
Challenging innate immune receptors leads to translocation of transcription factors to the 
nucleus and to activation of MAP kinases. These molecules induce a wide spectrum of 
inflammatory responses such as induction of cytokines and chemokines (e.g. tumor necrosis 
factor (TNF), IFN-γ, or IL-1, IL-6, IL-8, IL-12 47, 81, 82), NO production83, expression of 
antimicrobial peptides (e.g. human β-defensin (hBD)-284), apoptosis30, dendritic cell 
maturation including up-regulation of major histocompatibility complex (MHC) molecules 
and co-stimulatory molecules like CD80 and CD86, two signals necessary for T cell 
activation85, 86. 
Other systems producing inflammatory mediators are the kinin system, the clotting system, 
the fibrinolytic system, and the complement system. The kinin system is activated following 
tissue injury and produces potent vasoactive mediators that increase vascular permeability, 
cause vasodilation, induce pain, and contraction of smooth-muscle. The clotting system is 
triggered by damage to blood vessels and prevents bleeding and limits the spread of invading 
pathogens into the bloodstream, but it increases the vascular permeability and neutrophil 
influx. The fibrinolytic system removes fibrin clots from injured tissues. Degradation 
products are chemotactic for neutrophils. Finally, the complement pathway results in 
formation of complement split products that serve as important mediators of inflammation. 
These mediators induce smooth-muscle contraction and increase vascular permeability. 
Neutrophils and monocytes migrate towards the site of complement activation in tissues. The 
complement system is composed of more than 20 serum proteins and cell surface receptors, 
which assemble to a membrane attack complex that introduces pores into the membrane of 
invading pathogens such as bacteria87. 
Following membrane perturbations several cell types like macrophages, monocytes, 
neutrophiles, and mast cells produce prostaglandins, thromboxanes, and leukotrienes. These 
lipid inflammatory mediators induce smooth-muscle contraction and are potent 
chemoatractants of neutrophils. 
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4.3 The adaptive immune system 
4.3.1 T helper cell activation 
Naïve CD4+ T helper (Th) cell activation is initiated by interaction of the T cell receptor 
(TCR) - CD3 complex with a processed antigenic peptide bound to MHC class II molecules 
presented on antigen-presenting cells (APC). The TCR dictates the antigen specificity of the 
response and plays the central role in initiating T cell activation88. Released cytokines and co-
stimulatory molecules of activated Th cells control the adaptive immunity. These cytokines 
induce B cell proliferation and determine the isotype of antibodies secreted by B cells and 
thereby the effector function of the adaptive immune response. 
MHC class II molecule. MHC class II molecules are membrane bound glycoproteins 
constituting of one α and one β polypeptide chain encoded by multiple α and β chain genes. 
Three isotypes of human MHC class II molecules exist, which are named according to the 
corresponding gene regions HLA-DR, HLA-DQ, and HLA-DP89. MHC class II molecules 
have two external domains built by the α1 and α2 domains of one chain and the β1 and 
β2 domains of the other chain. The α1 and β1 form the highly polymorphic peptide binding 
cleft. MHC class II molecules are primarily expressed on thymic epithelial cells, activated T 
cells, and APC such as B cells, monocytes/macrophages, and DC. Exogenous antigens are 
processed in endocytic vesicles and loaded on MHC class II molecules. Resulting peptide - 
MHC class II complexes move to the plasma membrane. Expression of MHC class II 
molecules is regulated through class II transactivator (CIITA). The structure of CIITA is 
homologous to the NOD proteins because of the C-terminal LRR for ligand binding, the 
NOD, domain and the CARD transcription enhancer domain. Furthermore, CIITA has a N-
terminal transcription activator domain, enabling CIITA to interact with co-factors for 
induction of transcription. CIITA itself does not bind DNA, but it associates with four DNA-
binding factors: regulatory factor X (RFX) 5, RFX-associated protein (RFXAP), RFX-
associated ankyrin-containing protein (RFXANK), and the X2-box-binding factor cyclic-
AMP-responsive-element-binding protein (CREB). Ligands interacting with CIITA are not 
known. CIITA transcription is up-regulated through IFN-γ. Furthermore, there is a number of 
genes that are repressed by CIITA, including those encoding IL-4 and IL-1090-93. 
T cell receptor. The TCR is a heterodimer constituting of an α and a β chain or a γ and a δ 
chain. TCR composed of α and β chain is much more abundant than the γ/δ-TCR. The 
extracellular domain is folded in two immunoglobulin domains consisting of a constant (C) 
and a variable (V) region, structurally homologous to the variable and constant domains of 
immunoglobulin. Both chains of TCR have a positively charged transmembrane region and a 
short cytoplasmic tail. The positively charged transmembrane region enables heterodimer 
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formation with the negatively charged chains of the signal-transducing CD3 complex. TCR is 
expressed after immature T cells migrated from bone marrow to the thymus88. 
The α chain of the TCR is encoded by V, J, and C gene segments on germ-line DNA, the β 
chain by V, D, J, and C gene segments. Rearrangement of α and β chain gene segments 
results in VJ joining for the α chain and in VDJ joining for the β chain. V, D, and J gene 
segments are flanked by recognition signal sequences (RSS) recognized by recombinase 
enzymes recombination-activating genes (RAG-1 and RAG-2) catalyzing the V-J and V-D-J 
joining. The diversity of the TCR is achieved by combinatorial joining of variable-region 
gene segments generating a large number of random gene combinations. Diversity is further 
increased by alternative joining of D gene segments in different numbers yielding VDDJ or 
VDDDJ segments. Junctional flexibility, P-region nucleotide addition, and N-region 
nucleotides further enhance the diversity of the TCR considerable88. 
After T cell rearrangement, immature thymocytes undergo a positive selection resulting in 
MHC restriction. Those cells survive that carry a TCR capable of binding self-MHC 
molecules. In the negative selection process, all T cells expressing high affinity receptors to 
self-MHC molecules alone or self-antigen presented by self-MHC are eliminated, a process 
resulting in self-tolerance. The mature T cell migrates to the periphery, ready to get activated. 
However, the signal through the TCR is not sufficient to fully activate a naïve T cell. A co-
stimulatory signal provided by the interaction of CD28 of the T cell and CD80/CD86 of the 
APC is necessary, too88. 
T helper cell activation and differentiation. APC are central to T lymphocyte activation. 
APC take up antigens in peripheral tissues, become activated and migrate to lymphoid tissues 
to present the antigenic peptides on MHC class II molecules. Depending on the density of the 
peptides presented, types of co-stimulatory molecules expressed and cytokines released by the 
APC, naïve T helper cells start to proliferate and differentiate into T effector cell subsets, T 
helper cell type (Th) -1, Th-2, T regulatory cell (Treg), and Th-17 (Figure 4). The activation 
of CD8+ cytotoxic T lymphocyte (CTL) requires similar signals, except peptides must be 
presented by MHC class I molecules and memory CTL need additional signals of the T helper 
cells to become activated. The principal pathway, by which APC become activated to provide 
the signals to naïve T cells occurs via TLR recognition of pathogens94. 
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FIGURE 4. Activation of T helper cells by antigen-presenting cells. APC become activated through 
engagement of antigenic structures by a receptor of the innate immunity (PRR) leading to up-
regulation of co-stimulatory molecules and secretion of cytokines. Furthermore, foreign molecules are 
internalized, processed, and short antigenic peptides are presented on MHC class II molecules to the 
TCR of a T helper cell. All three signals induce T helper cell activation and differentiation. T helper 
cell differentiation is determined by the type of cytokines present and by the strength of the activating 
signals. APC, antigen-presenting cell; Th, T helper cell; Treg, T regulatory cell; TCR, T cell receptor. 
TLR-induced IL-12 production of APC generally induces differentiation towards Th-1 
cells. Immunization of mice with high dose of TLR ligands or complete Freund’s adjuvant 
results in Th-1 response. Furthermore, mice lacking MyD88 show impaired Th-1 but normal 
Th-2 responses94-96. By contrast, there are studies describing a Th2 response after triggering 
TLR294, 97, 98. Finally, low dose of inhaled LPS induces a Th-2 response, while high dose of 
LPS induces a Th-1 response in mice99. We found in chapter 2 that exposure to environmental 
microbial components of children fail to skew the T helper cell balance. Other factors that 
influence the T cell differentiation are the notch ligands, jagged1 and delta1 expressed on 
APC. Delta1 interaction with notch3 leads to Th-1 differentiation, while jagged1 interaction 
with notch1 mediates differentiation in Treg cells100-102. 
Th-1 response is characterized by the secretion of IL-2, TNF-β, and IFN-γ induced by 
transcription factor T-bet103. IFN-γ mediates secretion of high affinity IgG2a antibodies in B 
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cells and activates macrophages but inhibits Th-2 cells. Dysregulation of the Th-1 response is 
associated with autoimmunity and inflammatory diseases. 
Th-2 cell differentiation, evolved to enhance clearance of parasites, is induced by IL-4. Th-
2 cells express transcription factor GATA-3 enhancing the secretion of IL-4, IL-5, and IL-
13104. These cytokines activate eosinophils, mast cells, and mediate IgE secretion in B cells, 
but inhibit Th-1 cells. Dysregulated Th-2 response is associated with allergies and asthma. 
Treg cells act as suppressor for Th-1 and Th-2 cells and are therefore important regulators 
of the immune response. The suppression depends, at least in part, on cell to cell contact105. 
There are two subgroups of Treg cells, antigen-specific Treg cells and non-specific or 
naturally occurring Treg cells. Furthermore, Treg cells are characterized through expression 
of the transcription factor FOXP3 and secrete elevated amounts of the cytokines IL-10 and 
TGF-β106, 107. Since these cells should not interfere with induction of pathogen-specific 
protective immune response, TLR-mediated IL-6 production of APC blocks the suppressive 
activity of Treg cells94, 108. Furthermore, stimulation of TLR8 bearing Treg cells by TLR 
ligand reverses their suppressive function109. By contrast, direct TLR4 challenge of Treg cells 
with high concentrations of LPS elicits their proliferation, prolongs their survival, and 
augments their in vitro suppressive activity110, 111. 
Th-17 cells are induced through TGF-β and IL-6 and produce high amounts of IL-17. IL-
23 is important for amplifying and stabilizing the Th17 phenotype. The development of Th-17 
cells is blocked by IL-4 and IFN-γ and it seems that these cells have a function in suppressing 
autoimmune disease112, 113. 
4.3.2 B cell activation 
B cells produce antibodies, a most effective tool of the immune system to fight infections. 
B cells mature in the bone marrow. During maturation, the process of gene rearrangement of 
B cell receptors (membrane bound form of antibody) takes place to generate antibodies with a 
vast diversity of binding specificities. Mechanistically, the process is quite similar to the 
rearrangement of the TCR genes. The antibody light chain gene consists of a V, J, and C gene 
segment, while the antibody heavy chain gene contains a V, D, J, and C gene segment. 
Antibody diversity is generated by multiple germ-line gene segments, combinatorial V-(D)-J 
joining, junctional flexibility, P-region and N-region nucleotides addition, and combinatorial 
association of light and heavy chains. 
After maturation, B cells bearing the immunoglobulin (Ig, antibody) isotype M on the cell 
surface migrate to peripheral lymphoid organs, where they get activated through antigenic 
contact. Further signals required for B cell activation come from the T helper cell. The 
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interaction of CD40 with CD40 ligand on the T helper cell provides the second activation 
signal. The third signal comes from cytokines secreted by T helper cells. 
Immunoglobulin class-switch recombination. After immunization with antigen, B cells 
proliferate for about a week. Then, they migrate to germinal centers of secondary lymphoid 
organs, where somatic hypermutation and class-switch recombination (CSR) take place. Via 
somatic hypermutation, point mutations are induced in the variable region of the antibody 
gene to generate antibodies with enhanced specificity. B cells bearing receptors with the 
highest affinity to the antigen are selected by affinity maturation. By contrast, CSR exchanges 
the constant region of the antibody, generally Cµ (IgM) by Cγ (IgG), Cα (IgA), or 
Cε (IgE) (Figure 5). CSR changes the antibodies’ effector function. Both processes have in 
common that they occur in antigen-stimulated B cells, require transcription through the target 
region and require the enzyme AICDA (activated B cell specific enzyme activation-induced 
cytidine deaminase). But CSR has no well-defined consensus target sequence114 and does not 
necessarily have to take place in lymph nodes115. 
 
FIGURE 5. Immunoglobulin class-switch recombination. Immunoglobulin class-switch recombination 
takes place a few days after induction of proliferation of B cells changing the effector funtion of an 
antibody. During CSR a large piece of DNA is excised. The process is initiated after transcription of 
germ-line transcripts starting at the I promotor generating a single stranded R-loop structure accessible 
for CSR recombinase AICDA. GLT, germ-line transcript; CSR, class-switch recombination; AICDA, 
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activation-induced cytidine deaminase. (Adapted from Geha et al., Nat Rev Immunol. 2003 Sep, 3 (9): 
721-32) 
CSR is mediated through a recombination event between two switch (S) regions. S-regions 
are special DNA sequences located 5’ of the constant region of antibodies. S-regions consist 
of highly repetitive G-rich sequences of 1-12 kilobases length. To initiate CSR, the S-region 
is transcribed from the cytokine controlled I exon promotor located upstream of the S-region. 
The transcript (sterile transcript/germ-line transcript) includes the S-region and the 
corresponding immunoglobulin constant region. It is spliced by fusing the I exon to the 
constant region exon deleting the S-region sequence. Sterile transcripts are not translated into 
protein. Association of sterile transcript with DNA forming RNA-DNA hybrids generates a 
single stranded R-loop structure that is accessible to the CSR recombinase AICDA114, 116, 117. 
The enzyme AICDA introduces deoxyuridine in the S-region of the DNA by deamination 
of cytidine118. The DNA might be processed by several DNA repair pathways leading to a 
DNA double strand break. CSR is completed after joining of two broken S-regions, generally 
the S-region of Cµ with one of the other constant regions by non-homologous end-joining 
proteins114, 116. 
Regulation of CSR. For induction of immunoglobulin class switching, two signals are 
required. The CSR activation signal occurs either depending on or independently of T helper 
cells. A second signal is provided by cytokines determining the isotype of the antibody. 
The CSR induction signal provided by T helper cells is mediated by CD40 ligand 
interacting with CD40 receptor on the B cell. Furthermore, T helper cells secrete cytokines 
affecting the immunoglobulin isotype. The Th-1 cytokine INF-γ leads to switching to IgG2a 
and IgG3. The Th-2 cytokine IL-4 mediates switching to IgE and IgG1. 
T helper cell independent signals inducing immunoglobulin class switching are mediated 
by the B lymphocyte stimulator protein (BAFF or BLyS) and by a proliferation-inducing 
ligand (APRIL). BAFF is found in a membrane bound and in a soluble form, while APRIL 
only functions as soluble factor. BAFF is primarily expressed by cells of the innate immunity 
such as neutrophils, but also by monocytes, macrophages, DCs, and activated T cells. APRIL 
is expressed by monocytes, macrophages, DCs, and T cells. BAFF and APRIL are structurally 
related and both are members of the TNF family. They are induced through LPS, CD40 
ligand, and cytokines like IL-10, IFN-γ, and IFN-α. BAFF binds to three receptors selectively 
expressed by B cells, including transmembrane activator and calcium modulator and 
cyclophylin ligand interactor (TACI), B cell maturation antigen (BCMA), and BAFF receptor 
(BAFF-R or BR3). APRIL only interacts with BCMA and TACI, but not with BAFF-R. 
Binding of receptors by BAFF or APRIL activates a CD40-like pathway enhancing B cell 
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survival, maturation, and immunoglobulin class switching to IgG, IgA, and IgE in presences 
of cytokines like IL-4, IL-10, and TGF-β119-121. Over-expression of BAFF in mice not only 
augments B cell proliferation, but also T helper cell expansion. Furthermore, over-expression 
of BAFF leads to an induction of Th-1 response and enhanced incidence of autoimmune 
diseases122. 
CSR to IgE. Class switching to IgE is under tight control. The principal regulation event is 
induction of the Cε germ-line transcription. The Th-2 cytokine IL-4 and to a minor extend IL-
13 induces Cε germ-line transcription through activation of the transcription factor STAT6 
(signal transducer and activator of transcription 6). IL-18 also promotes class switching to IgE 
in an indirect manner. IL-18 enhances CD40 ligand expression on T helper cells and the 
release of IL-4, IL-10, IL-13, and IFN-γ123. 
IFN-γ inhibits the development of Th-2 cells and therefore the release of IL-4 and IL-13. 
Additionally, it blocks Cε germ-line transcription through direct interaction with B cells. IL-
21 represses IgE production by inhibiting Cε germ-line transcription via unkown 
mechanisms124, 125. The B cell surface receptors CD45, cytotoxic T lymphocyte antigen 
(CTLA) 4, low affinity IgE receptor CD23, and the B cell receptor seem to inhibit Cε germ-
line transcription, too. B cell lymphoma 6 (BCL6) inhibits Cε germ-line transcription by 
binding to the STAT6 sites on the Iε promotor. Furthermore, mice lacking BCL6 over-express 
Th-2 cytokines and have increased eosinophilia. TGF-β induces the expression of inhibitor of 
DNA binding (ID) 2. ID2 has a dual effect on IgE CSR. First, it regulates Th-1/Th-2 balance 
by regulating DC and secondly, it suppresses the Cε germ-line transcription in B cells123, 126, 
127. We found that only T helper cell dependent mechanisms are responsible for CSR to IgE in 
contrast to T helper cell independent mechanisms (Chapter 2). 
Allergy. Allergens are a certain type of antigens that induce IgE antibodies. Plasma cells of 
patients suffering from allergies and asthma secrete IgE instead of IgG in response to 
allergens and have therefore elevated serum levels of IgE. The predisposition to produce IgE 
antibodies is called atopy. IgE binds to Fc ε receptors on mast cells and basophils (Figure 6). 
These cells have granules containing pharmacologically active mediators. Basophils circulate 
in the blood stream making out about 0.5-1.0% of blood cells. Mast cells are found in tissues 
like skin or mucous membrane surfaces of the respiratory and gastrointestinal tracts. The skin 
contains around 10’000 mast cells per mm3. Cross-linking of IgE bound to Fc ε receptors by 
allergens leads to degranulation of the mast cells and basophils. Inflammatory mediators like 
histamine, leukotrienes, prostaglandins, and cytokines like IL-4, IL-5, IL-6, and TNF are 
released. The mediators cause smooth-muscle contraction, increased vascular permeability, 
and vasodilatation resulting in the allergic symptoms. 
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FIGURE 6. Mast cell and basophil degranulation. Cross-linking of IgE bound to Fc ε receptors on 
mast cells and basophils leads to secretion of inflammatory mediators like histamines, leukotrienes, 
prostaglandins, and cytokines resulting in allergic symptoms. (Adapted from Geha et al., Nat Rev 
Immunol. 2003 Sep, 3 (9): 721-32) 
5. Objectives of this study 
For a long time, the development of allergic diseases has been thought to be largely based 
on genetic predisposition. More recent epidemiological studies have shown that 
environmental factors are important, too. Not all children with a genetic predisposition 
develop allergic diseases. The hygiene hypothesis proposes that living in ‘dirty’ 
environments, as we find it on a farm, protects many of these children against the 
development of allergic disorders. 
The immunological mechanisms underlying the hygiene hypothesis are the principal issue 
of this study. The prevailing immunological interpretation of the hygiene hypothesis is that 
decreased exposure to environmental microbial components or infections result in a shift of 
the Th-1/Th-2 balance. Reduced cellular activation through TLR by microbes in the 
environment reduces IL-12 and INF-γ secretion of APC resulting in development of Th-2 
responses, finally resulting in allergic diseases. This interpretation of the hygiene hypothesis 
seems to be too simple. First, not only Th-2 associated diseases have increased over the past 
decades in parallel with improved hygiene but also Th-1 associated inflammatory and 
autoimmune diseases4, 128. Secondly, infection with helminth parasites induces a strong Th-2 
response with eosinophilia, mucosal mastocytosis, and production of IgE. Children having 
parasitic infection suffer less from allergies than uninfected129, 130. 
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Recently, Treg cells have been proposed to serve as immunological explanation for the 
hygiene hypothesis due to their suppressive activity on Th-1 and Th-2 effector cells. 
Furthermore, Treg cells are induced during allergen injection immunotherapy leading to 
suppression of Th-2 responses and to a switch from IgE to IgG4 antibody production131. But 
the findings that Treg cells are inactivated after TLR stimulation with bacterial components is 
in contrast to the protective role of bacterial components. 
In chapter 2 of this study we checked whether these proposed immunological 
interpretations of the hygiene hypothesis were reproducible in the children of the ALEX and 
the PARSIFAL studies. We investigated whether the protective effect of environmental 
exposure of children to microbes was due to a shift in Th-1/Th-2 differentiation or due to 
altered generation of Treg cells. Therefore, we measured the expression of marker genes of T 
helper cells in blood leukocytes from children and assessed correlations between their 
expressions and exposure to environmental factors such as endotoxin in mattresses and living 
rooms, stable and animal contact of the mother during pregnancy, or living on a farm.  
Since the innate immune system not only directs T helper cell differentiation but also 
inflammatory responses and T helper cell independent immunoglobulin isotype switching, we 
investigated whether regulatory molecules of the TLR signaling cascade have a protective 
role against allergies and inflammation in children. The expression of the SOCS-1 gene and 
of the ST2 gene has been described to be regulated by TLR ligands, thereby inducing 
endotoxin tolerance. This, in turn, was associated with protection against inflammatory and 
autoimmune diseases for SOCS-1 and with protection against allergies for ST2. We measured 
the expression of these genes in blood leukocytes of the children of the ALEX and 
PARSIFAL studies and assessed correlations with exposure to microbial components in the 
environment and with markers of inflammatory and allergic responses (Chapter 3 and 4). 
Next, we investigated whether MHC class II molecules, additionally to their role in 
initiating adaptive immune responses, play a role in the regulation of the innate immune 
system, too. We studied this with cell culture experiments, where we co-expressed HLA-DR1 
and TLR2 and confirmed our results in a mouse model (Chapter 5). 
In the PARSIFAL cohort, we had a substantial number of women who stopped working on 
the farm after pregnancy, enabling us to distinguish between prenatal and early childhood 
exposure. Epidemiological analysis showed that prenatal exposure of the children to stable 
and farm animals was highly protective against the development of allergies. We thus were 
interested in possible changes in innate immunity. We investigated this in two ways. First, we 
studied whether expression of CD14, TLR2, and TLR4 correlated with prenatal exposure of 
the PARSIFAL children. We chose these three receptors because their expression was 
strongly regulated through farm-lifestyle (Chapter 6)27. In a second part, we studied whether a 
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single bacterial challenge was enough to induce persistent changes in the innate immune 
system indicating a memory function. To assess this, we designed a mouse model where we 
treated newborn mice with bacterial components. After three months, we assessed the 
expression of different genes of innate immunity in organs of the immune system (Chapter 7). 
In this work, we found that the proposed mechanisms underlying the hygiene hypothesis 
have no relevance in protecting farm children against allergies. Rather, we observed that 
regulatory mechanisms of the innate immune system are able to reduce inflammatory 
responses and IgE levels of children. 
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Abstract 
Background: A shift of T helper cell balance towards T helper cell type (Th) 1 or 
generation of T regulatory (Treg) cells has been proposed as immunological basis of the 
hygiene hypothesis. Objective: We investigated whether a skewing of the T helper cell 
balance or a change in the generation of Treg cells could be observed in farmers’ children. 
Furthermore, we assessed if either T cell dependent or T cell independent mechanisms 
resulted in immunoglobulin isotype switching to IgE. Methods: The expression of T helper 
cell makers and Cε germ-line transcripts was assessed in blood leukocytes of farmers’ and 
non-farmers’ children from the Swiss subsample of the PARSIFAL population using 
quantitative real-time PCR. Results: We found that the expression of some genes associated 
with Th-1 differentiation correlated with environmental conditions created by farming. 
However, as indicated by the expression of transcription factors T-bet, GATA-3, and FOXP3, 
protection against allergies in the farming population investigated here could not solely be 
explained by a skewing of Th-1/Th-2 balance or a change in the generation of Treg cells. 
Furthermore, T cell activation assessed by the expression of CD40 ligand, T-bet, GATA-3, 
and FOXP3 correlated with immunoglobulin isotype switching to IgE. In contrast, gene 
expression of pattern recognition receptors regulated via the exposure to environmental 
factors and the expression of BAFF was negatively associated with immunoglobulin isotype 
switching to IgE. Conclusion: Mechanisms of the innate immune system may constitute the 
immunological basis of the hygiene hypothesis. 
Introduction 
The hygiene hypothesis was proposed after observing a lower risk of hay fever and atopic 
sensitization in children with more siblings1. The protective effect was attributed to elevated 
infections during childhood. Other findings have supported this hypothesis. Early enrollment 
in a day nursery, for example, has protective effects against the development of allergies 
while Italian military students with antibodies against hepatitis A virus have a lower 
prevalence of atopy and atopic respiratory diseases2, 3. 
Other studies have shown that a rural lifestyle, in addition to infections, protect children 
against allergies4. Contact to farm animals in particular was demonstrated to be highly 
protective5, 6. The protective effects of a farm were attributed to exposure to higher loads of 
bacterial components as shown for endotoxin, a lipopolysaccharide (LPS) of the outer layer of 
the cell membrane of Gram-negative bacteria7, 8. Furthermore, child’s consumption of non-
pasteurized milk and working of the mother in stable or with stable animals during pregnancy 
have protective effects on children9. Farmers’ children have reduced IgE levels in serum and 
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their blood leukocytes express more Toll-like receptors (TLR), the principal family of pattern 
recognition receptors (PRR) of the innate immune system7, 9-11. 
The leading immunological interpretation of the hygiene hypothesis is that decreased 
infections or exposure to environmental microbial components result in a shift of T helper cell 
type (Th)-1/Th-2 balance1, 12, 13. Cytokines and co-stimulatory molecules of innate immunity 
direct T helper cell activation and differentiation. The Th-1 response is initiated by interleukin 
(IL)-12 and is characterized by IL-2, tumor necrosis factor (TNF)-β, and gamma interferon 
(IFN-γ) secretion. IFN-γ inhibits Th-2 cell differentiation and mediates secretion of IgG 
antibodies by B cells. Th-1 differentiation is controlled by transcription factor T-bet and is 
associated with inflammation and autoimmunity14. IL-4 induces a Th-2 response. Th-2 
specific genes are regulated by transcription factor GATA-3 enhancing IL-4, IL-5, and IL-13 
expression. These cytokines inhibit Th-1 differentiation and induce immunoglobulin class-
switch recombination (CSR) to Cε in B cells. Thereby, Th-2 response is associated with 
allergic diseases15. The binding of ligands to a TLR leads to the translocation of NF-κB to the 
nucleus and to MAP kinase activation ending in the secretion of inflammatory, Th-1 
associated cytokines: TNF and IL-1216, 17. The absence of TLR activating signal caused by 
fewer infections or low levels of microbes in environment decreases IL-12 secretion of the 
innate immune system resulting in development of Th-2 responses mediating immunoglobulin 
CSR to Cε in B cells16. 
Recently, T regulatory cells (Treg) were proposed as another immunological explanation 
for the hygiene hypothesis due to their suppressive activity on Th-1 and Th-2 effector cells18. 
Enhanced hygiene conditions may lead to loss of suppressive activity of Treg cells19. The 
Treg cell phenotype is controlled by transcription factor FOXP3. The suppressive activity 
depends on cell to cell contact20 in addition to the secretion of immunosuppressive cytokines 
IL-10 and TGF-β21, 22. 
Immunoglobulin CSR exchanges the constant region of antibody, generally Cµ (IgM) to 
Cγ (IgG), Cα (IgA), or Cε (IgE). Immunoglobulin CSR is induced by T helper cells through 
the interaction of CD40 ligand (CD40L) with CD40 on B cells. Released cytokines determine 
the isotype to which the antibody constant region switches. The innate immune system has the 
ability to induce immunoglobulin CSR, too, without the contribution of T helper cells. T 
helper cell independent immunoglobulin CSR is mediated by various molecules such us 
BAFF (B lymphocyte stimulator protein) or APRIL (a proliferation-inducing ligand), two 
soluble factors mainly expressed by cells of the innate immune system. BAFF binds to three 
receptors primarily expressed by B cells, including transmembrane activator and calcium 
modulator and cyclophylin ligand interactor (TACI), B cell maturation antigen (BCMA), and 
BAFF receptor (BAFF-R or BR3). APRIL only interacts with BCMA and TACI, but not with 
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BAFF-R. The binding of BAFF or APRIL by receptors enhances B cell survival, maturation, 
proliferation and immunoglobulin CSR23-25. 
CSR is mediated by a recombination event between two switch (S) regions. S-regions are 
special DNA sequences located 5’ of the constant region of antibodies consisting of highly 
repetitive G-rich sequences of 1-12 kb in length. To initiate CSR, the S-region is transcribed 
from the cytokine controlled I exon promotor located upstream of the S-region. The 
transcripts (sterile transcripts/germ-line transcripts, GLT) include the S-region and the 
corresponding immunoglobulin constant region. They are spliced by fusing the I exon to the 
constant region exon and deleting the S-region sequence. GLT are not translated into protein. 
Association of a GLT with the DNA forming RNA-DNA hybrids generates a single stranded 
R-loop structure that is accessible for the CSR recombinase AICDA (activation-induced 
cytidine deaminase)26-28. AICDA introduces deoxyuridine in the S-region of the DNA by 
deamination of cytidine29. The DNA might be processed by several DNA repair pathways 
leading to a double strand break in the DNA. CSR is completed after joining of two broken S-
regions by non-homologous end-joining proteins26, 27. 
The goal of the PARSIFAL (Prevention of Allergy Risk factors for Sensitization In 
children related to Farming and Anthroposophic Lifestyle)30 study was to identify factors 
making rural lifestyle so protective against allergies in children9. Here, we investigated 
whether the proposed immunological mechanisms for the hygiene hypothesis were relevant in 
a human system in a Swiss subsample of the PARSIFAL study. We assessed whether factors 
previously identified as highly protective against the development of allergic diseases shifted 
T helper cell differentiation towards Th-1 or enhanced the generation of Treg cells, thereby 
leading to less immunoglobulin CSR to IgE in these children. We found that none of the 
protective environmental factors was associated with a shift towards Th-1 or Treg cell 
differentiation. Furthermore, we found that the expression of the CD40L gene as well as that 
of T helper cell marker genes were positively associated with immunoglobulin CSR to IgE. 
By contrast, the expression of both, the BAFF gene and pattern recognition genes of the 
innate immune system, correlated with lower immunoglobulin CSR to IgE. These results 
indicate that exposure to microbial components, as they are found on a farm, activates 
mechanisms of the innate immune system leading to protection against immunoglobulin CSR 
to IgE and thereby protecting against the development of allergies, while T cell response 
remains unaffected. 
Methods 
Population and questionnaire. We assessed the expression of relevant T helper cell 
marker genes and of genes of the innate immune system in the Swiss branch of the 
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PARSIFAL study. RNA samples were collected from 195 farm and 127 reference children 
(95.3% of children who provided blood samples) to analyze gene expression9. Parents of 
participating children were invited to fill out questionnaire used in this study. Questions on 
farming lifestyle and farm exposures were derived from the internationally validated 
International Study of Asthma and Allergies in Childhood II31 questionnaire and the Allergy 
and Endotoxin study32, respectively. 
Measurement of endotoxin and fungal extracellular polysaccharides in dust samples. 
Endotoxin and fungal extracellular polysaccharides (EPS) were measured in mattress dust 
samples of 83.9% of children with complete gene expression data (n = 270). Sampling and 
detection methods are described elsewhere33. In brief, endotoxin was measured with the 
kinetic chromogenic Limulus Amebocyte Lysate test (Bio Whittaker) and EPS with a specific 
sandwich enzyme immunoassay for EPS of Aspergillus and Penicillium species9, 34. We 
divided the children in three groups due to the amount of endotoxin or EPS in mattress’ dust 
samples. The expression values of genes of the group with highest endotoxin or EPS amounts 
were related to group with the lowest. 
RT-PCR and quantitative real-time PCR (TaqMan®). The total RNA was isolated as 
described 9 and stored at minus 80°C. For reverse transcription (RT) of RNA we used 300ng 
of total RNA in a final volume of 30µl and added adequate amounts of TaqMan® Reverse 
Transcription Reagents (Applied Biosystems). The quantification of Cε germ-line transcripts 
we used the ABI Prim 7700 Sequence Detection System (Applied Biosystems) and the 
following primers: forward 5’-ACAGGCACCAAATGGACGAC-3’, reverse 5’-
TTGCAGCAGCGGGTCAA-3’. The minor groove binding probe had the sequence 5’-
CACAGAGCCCATCCG-3’. The quantification of the other genes was performed on an ABI 
Prism 7900 Sequence Detection System (Applied Biosystems) using the TaqMan® low 
density array (LDA) system of Applied Biosystems. The determined gene expression values 
were normalized to the parallel measured endogenous controls 18S rRNA. We analyzed the 
data with the comparative Ct method according to the manufacturer’s instructions (Applied 
Biosystem). 
Results 
We investigated whether living on a farm or exposure to environmental factors associated 
with protection against the development of allergies resulted in skewing of Th-1/Th-2 balance 
or in induction of Treg cells in children of a Swiss subsample of the PARSIFAL study. We 
measured the expression of marker genes of Th-1, Th-2, and T reg cells in blood leukocytes 
of children by quantitative real-time PCR and related it to environmental exposure factors 
(Table 1). The expression of T-bet gene, being the most specific marker for Th-1, failed to 
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associate with environmental exposure factors. Furthermore, we assessed expression of 
chemokine receptors CCR5 and CXCR3 as Th-1 markers35, 36. Only CXCR3, which is also 
expressed on mast cells37, showed a positive correlation with analyzed environmental 
exposure factors. Expression of Th-2 marker genes, transcription factor GATA-3 and 
chemokine receptors CCR4 and CCR835, 36 were positive associated with environmental 
factors such as farming, exposure of the mother during pregnancy, child’s consumption of 
non-pasteurized milk, or fungal extracellular polysaccaraides (EPS) in child’s mattress. By 
contrast, expression of the Th-2 associated chemokine receptor CCR3 gene was significantly 
decreased. CCR3 is not selectively expressed on Th-2 cells, but is also found on eosinophiles 
and basophiles38. Expression of Treg cell marker gene FOXP3 was unaffected by 
environmental exposure factors. 
 
T helper cells exhibit their function via the release of a specific cytokine pattern. We 
investigated whether environmental exposure factors correlated with cytokine pattern secreted 
by T helper cells (Table 2). Gene expression of Th-1 differentiation inducing cytokine IL-12 
was not affected by environmental exposure factors. But gene expression of IFN-γ, secreted 
by Th-1 cells was clearly down-regulated in blood leukocytes of children living in farming 
lifestyle. Gene expression of Th-2 associated cytokine IL-4 was enhanced in children living 
on a farm being in line with induced Th-2 transcription factor GATA-3. IL-13 gene 
expression was unaffected by the environmental exposure factors. The expression of the 
inhibitory cytokine IL-10 was highly induced while the expression of TGF-β was only 
slightly increased related to environmental exposure factors. Therefore, farming lifestyle 
failed to skew T helper cell balance or induced Treg cell differentiation, but decreased INF-γ 
and enhanced IL-10 and TGF-β secretion. 
TABLE 1. Association between environmental exposure factors and T helper cell marker
Environmental exposure factor Th-1 associated Treg associated
T-bet CCR5 CXCR3 FOXP3
Being a farm child 1.03 (0.87-1.23) 1 (0.77-1.28) 2.02 (1.5-2.7)** 0.97 (0.82-1.15)
Number of animals the mother had contact during pregnancy 0.97 (0.92-1.03) 1 (0.93-1.09) 1.23 (1.12-1.35)** 1 (0.95-1.05)
Maternal work in stable during pregnancy 1.04 (0.87-1.24) 0.91 (0.7-1.18) 1.82 (1.35-2.46)** 1.01 (0.85-1.19)
Child's consumption of non-pasteurized milk 0.99 (0.82-1.18) 1.03 (0.79-1.33) 1.74 (1.29-2.35)** 0.94 (0.79-1.11)
Endotoxin in mattress (EU/g dust) 0.89 (0.72-1.1) 1.06 (0.78-1.45) 1.39 (0.96-2)+ 1.08 (0.88-1.32)
EPS in mattress (EPS/g dust) 0.99 (0.8-1.23) 0.98 (0.72-1.33) 1.51 (1.05-2.17)* 1.05 (0.86-1.28)
Environmental exposure factor Th-2 associated
GATA-3 CCR3 CCR4 CCR8
Being a farm child 1.25 (1.04-1.5)* 0.67 (0.51-0.9)** 1.22 (0.97-1.54)+ 2.24 (1.39-3.6))**
Number of animals the mother had contact during pregnancy 1.05 (0.99-1.11) 0.9 (0.83-0.99)* 1.09 (1.01-1.17)* 1.23 (1.07-1.43)**
Maternal work in stable during pregnancy 1.25 (1.03-1.5)* 0.77 (0.58-1.04)+ 1.27 (1-1.61)* 2.66 (1.64-4.31)**
Child's consumption of non-pasteurized milk 1.21 (1-1.46)* 0.7 (0.53-0.93)* 1.27 (1.01-1.6)* 2.11 (1.3-3.42)**
Endotoxin in mattress (EU/g dust) 1.07 (0.85-1.34) 0.88 (0.62-1.25) 1.29 (0.97-1.71)+ 1.47 (0.83-2.58)
EPS in mattress (EPS/g dust) 1.27 (1.02-1.58)* 0.95 (0.67-1.34) 1.09 (0.82-1.44) 1.39 (0.79-2.43)
+: 0.1 > p > 0.05, *: 0.05 > p > 0.01, **: p < 0.01
All values adjusted for sex, age, and parental history of atopy. Measure of effect size for all values: geometric means ratios and 95% confidence intervals; 
except for CCR8: Odds ratio and 95% confidence intervals
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We were also interested whether T helper cell balance was responsible for immunoglobulin 
CSR to IgE in blood leukocytes of children. We measured the expression of Cε GLT by 
quantitative real-time PCR. Since immunoglobulin CSR primarily takes place in lymph 
nodes, we also determined the expression of AICDA and Bach2 genes, two molecules 
absolutely necessary for immunoglobulin CSR39. Expression of AICDA and Bach2 genes was 
positively associated with expression of Cε GLT (Geometric means ratio 1.49, p<0.05 for 
AICDA and 1.62, p<0.01 for Bach2) indicating that immunoglobulin CSR took place in blood 
leukocytes of children. 
We then related expression of Cε GLT to gene expression of CD40L and to expression of 
T-bet, GATA-3, and FOXP3 (Figure 1). We found positive association between 
immunoglobulin CSR inducing molecule CD40L expressed on T cells and Cε GLT. 
Furthermore, expression of transcription factors T-bet, GATA-3, and FOXP3 correlated with 
expression of Cε GLT indicating that enhanced T cell activation associated with elevated 
immunoglobulin isotype switching to IgE. 
Since TLR expression of children was controlled by environmental exposure factors9, 10, 
we investigated whether mechanisms of the innate immune system may influence 
immunoglobulin CSR to IgE. We assessed gene expression of TLR2, TLR4, CD14, MD-2, 
and TREM1 and of immunoglobulin CSR inducing ligands APRIL and BAFF in blood 
leukocytes of children (Figure 1). We found that the expression of BAFF gene was negatively 
associated with expression of Cε GLT, while APRIL expression failed to correlate. 
Furthermore, gene expressions of pattern recognition receptors involved in recognition of 
bacterial components were negatively associated with expression of Cε GLT. 
TABLE 2. Association between environmental exposure factors and cytokines
Environmental exposure factor Cytokine
IL-12! IFN-" IL-4 IL-13 IL-10 TGF-#
Being a farm child 0.94 (0.73-1.21) 0.45 (0.32-0.63)** 1.73 (1.08-2.77)* 0.69 (0.3-1.59) 2.43 (1.7-3.48)** 1.11 (0.98-1.25)+
Number of animals the mother had contact during pregnancy 0.97 (0.9-1.05) 0.78 (0.7-0.86)** 1.08 (0.93-1.24) 0.91 (0.72-1.16) 1.32 (1.18-1.48)** 1.05 (1.01-1.09)**
Maternal work in stable during pregnancy 1.11 (0.86-1.43) 0.49 (0.35-0.7)** 1.56 (0.98-2.51)+ 0.58 (0.25-1.33) 2.28 (1.58-3.29)** 1.15 (1.02-1.3)*
Child's consumption of non-pasteurized milk 0.99 (0.77-1.28) 0.63 (0.45-0.89)** 1.58 (0.97-2.55)+ 1.57 (0.68-3.61) 2.13 (1.48-3.07)** 1.16 (1.02-1.3)*
Endotoxin in mattress (EU/g dust) 1.05 (0.78-1.43) 0.78 (0.51-1.19) 0.96 (0.54-1.7) 0.93 (0.32-2.67) 2.06 (1.33-3.21)** 1.09 (0.94-1.26)
EPS in mattress (EPS/g dust) 1.27 (0.94-1.71) 0.61 (0.4-0.93)** 1.18 (0.68-2.07) 0.73 (0.27-1.97) 2.04 (1.32-3.16)** 1.11 (0.96-1.28)
All values adjusted for sex, age, and parental history of atopy. Measure of effect size for all values: geometric means ratios and 95% confidence intervals; except for IL-4 and IL-13: Odds ratios and 95% confidence intervals
+: 0.1 > p > 0.05, *: 0.05 > p > 0.01, **: p < 0.01
 44 
 
FIGURE 1. Expression of T cell and innate immunity marker genes related to expression of Cε GLT 
in blood leukocytes of children. We associated expression of CD40L gene and of T helper cell or Treg 
cell marker genes to expression of Cε GLT (white bars). Furthermore, expression of PRR and 
immunoglobulin CSR inducing ligands BAFF and APRIL genes were related to expression of Cε GLT 
(black bar). Measure of effect size: geometric means ratios and 95% confidence intervals; all estimates 
adjusted for farming status, sex, age, and parental history of atopy; +: 0.1 > p > 0.05, *: 0.05 > p > 
0.01, **: p < 0.01. 
Finally, we were interested whether the expression of APRIL and BAFF gene associated 
either with environmental exposure factors or with TLR gene expression to assess a link 
between these ligands and the hygiene hypothesis. Expression of APRIL and BAFF gene 
failed to correlate with environmental exposure factors (data not shown), but we found 
positive associations between APRIL and BAFF gene expression and the expression of TLR 
genes (Table 3). 
Discussion 
In this study, we investigated whether T cell dependent or innate immune mechanisms led 
to immunoglobulin isotype switching to IgE in context of exposure to environmental 
microbial components in children. Our data showed that the widely proposed shift in T helper 
TABLE 3. Association between gene expression of PRR and APRIL or BAFF
Pattern recognition receptor
APRIL BAFF
TLR2 1.43 (1.31-1.57)** 1.67 (1.52-1.84)**
TLR4 1.58 (1.45-1.71)** 1.85 (1.7-2.02)**
CD14 2.06 (1.87-2.27)** 1.76 (1.55-2.01)**
MD-2 1.53 (1.43-1.64)** 1.72 (1.59-1.85)**
TREM1 1.43 (1.34-1.53)** 1.41 (1.3-1.53)**
All values adjusted for farming status, sex, age, and parental history of atopy. Measure of 
effect size for all values: geometric means ratios and 95% confidence intervals
+: 0.1 > p > 0.05, *: 0.05 > p > 0.01, **: p < 0.01
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cell balance to enhanced Th-1 differentiation via exposure to microbes, as they are found in 
farming environments, failed to take place in children. It seemed that farmers’ children had 
even more Th-2 cells as indicated by enhanced GATA-3, CCR4, CCR8 and IL-4 gene 
expression while IFN-γ gene expression was clearly reduced. Our findings coincide with other 
observations indicating that skewing Th-1/Th-2 balance may not be the immunological 
mechanism for the hygiene hypothesis. Not only have Th-2 associated diseases increased over 
the past decades in parallel with elevated hygiene conditions, but also Th-1 associated 
inflammatory and autoimmune diseases18, 40, 41. There are also patients with concurrent 
allergic diseases and autoimmunity13. And helminth parasite infection induces a strong Th-2 
response with eosinophilia, mucosal mastocytosis, and increased production of IgE. 
Interestingly, children having parasites infection suffer less from allergies than uninfected 
classmates42, 43. Our results together with these additional observations make skewing of T 
helper cell differentiation implausible as immunological mechanism for the hygiene 
hypotheses. 
Expression of Treg cells marker failed to correlate with environmental factors, too. 
Anyway, Treg cells as explanation for the hygiene hypothesis are unlikely because TLR-
mediated IL-6 production has been shown to block the suppressive activity of Treg cells44, 45. 
Furthermore, stimulation of TLR2 or TLR8 bearing Treg cells by TLR ligands reverses their 
suppressive function46, 47. Farming lifestyle induced the expression of suppressive cytokine 
IL-10. IL-10 inhibited inflammatory cytokine production by innate immunity and elicited 
anergy in T cells. But its role in allergic diseases remains controversial. IL-10 produced by 
dendritic cells promoted the development of Th-2 cells, while IL-10 was increased in patients 
with allergic asthma. In contrast, IL-10 appeared to have a role in allergen-specific 
immunotherapy, too19, 48, 49. In our study, we failed to find association between IL-10 
expression and allergic disorders or IgE in serum (data not shown). But the enhanced IL-10 
secretion together with the reduced IFN-γ level in farmers’ children indicate a diminished 
inflammatory responses and may thereby protect against the development against allergic 
diseases. 
Immunoglobulin CSR to IgE in peripheral blood was enhanced via T helper cell activation. 
We found positive association between all phenotype-specific T helper cell markers and Cε 
GLT. By contrast, pattern recognition receptor gene expression and the expression of BAFF 
seemed to protect against immunoglobulin CSR to IgE. Our study failed to explain how the 
innate immune system constitutes this protection. Principally, BAFF enhances B cell 
proliferation and immunoglobulin isotype switching to all constant regions23. It is possible 
that BAFF directed immunoglobulin CSR preferable to switching to Cγ. Furthermore, BAFF 
suppresses Th-2 response50-52. This mechanism was rather unlikely, as we failed to observe a 
shift in T helper cell differentiation in farmers’ children. Another role of BAFF is to elevate 
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TLR dependent B-1 cell activation53. B-1 cells are naturally occurring B cells secreting germ-
line encoded IgM and IgG and contributing to the first line defence of the immune system. 
Enhanced activation of B-1 cells might have led to decreased B-2 response, thereby reducing 
the generation of IgE mediated by B-2 cell. 
These data indicate that microbial level or other environmental exposure factors associated 
with reduced hygienic conditions of a farm failed to influence T cell differentiation. Skewing 
of the T helper cell balance may only become important if microbial levels are much higher, 
as it is the case during an infection. By contrast microbial levels of a farm left a mark on the 
innate immune system9, 10. Thereby induced mechanisms of the innate immune system reduce 
the inflammatory responses and have the potential to protect against allergies and may 
constitute the central immunological basis of the hygiene hypothesis. 
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Introductory paragraph 
Epidemiological studies have shown an increase in the incidence of allergic diseases in 
western countries during the past decades in parallel to a decrease in infectious diseases1. The 
hygiene hypothesis proposes that living in environments rich in microbes or predisposing to 
infections and thereby favoring T helper cell (Th) differentiation towards the Th-1 phenotype 
and away from the allergy promoting Th-2 phenotype underlies this protection against 
allergies2-5. However, similar environmental conditions have been found to protect against 
Th-1 associated autoimmune and auto-inflammatory diseases, too6. The frequency of these 
Th-1 associated diseases has risen in the past decades in western countries similar to Th-2 
associated allergies1, 7, 8. This might be considered an immunological contradiction. Thus, we 
searched for immunological mechanisms independent of the Th-1/Th-2 balance. 
Suppressor of cytokine signaling (SOCS)-1 protein is induced in response to microbes and 
suppresses inflammatory and autoimmune responses in mice9-11. We found that in children 
environmental exposure to the microbial component lipopolysaccaride (LPS/endotoxin) 
resulted in elevated expression of the SOCS-1 gene, which, in turn, correlated to decreased 
INF-γ responses and IgE levels. Thus, SOCS-1 may be part of an anti-inflammatory feedback 
mechanism contributing to protection against both allergic and autoimmune diseases by 
environmental microbes. 
Results and Discussion 
The relationship between environmental microbial exposure and allergies in children has 
been investigated in a cross-sectional epidemiologic study (Allergy and Endotoxin, ALEX)12-
14. We measured the expression of the SOCS-1 gene by quantitative real-time PCR in a 
subsample (n=43) of the ALEX cohort and determined the level of endotoxin in dust samples 
collected from the environment of the children. The exposure to endotoxin of the children 
ranged from 1,320 to 167,185 EU/m2 (geometric mean 14,797 EU/m2) in living rooms and 
from 2497 to 87,726 EU/m2 (geometric mean 10,885 EU/m2) in mattresses. The SOCS-1 gene 
expression in children’s PBL was positively associated with the endotoxin level in 
environment (Figure 1). The correlation coefficient of the expression of the SOCS-1 gene 
with the endotoxin load in children’s living room and mattress was 0.35 (p=0.0224) and 0.345 
(p=0.0236), respectively. Multivariate linear regression showed that a tenfold increase in 
endotoxin load in living room was associated with a 1.57 fold increase in SOCS-1 gene 
expression in children’s PBL (p=0.0086). This finding is in agreement with previously 
described results from mouse models15-18, where SOCS-1 protein was up-regulated by Toll-
like receptor (TLR) agonists such as LPS to negatively regulate LPS signaling. Macrophages 
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from SOCS-1 knock-out mice were hyper-responsive to LPS and produced increased amounts 
of pro-inflammatory cytokines9. SOCS-1 suppressed LPS induced NF-κB activation through 
direct interaction with interleukin-1 receptor-associated kinase (IRAK) and through 
degradation of the MAL (MyD88-adaptor like, also called TIRAP) protein, a cytosolic Toll-
interleukin 1 receptor (TIR) domain containing adaptor protein19, 20. Thus, SOCS-1 is an 
important molecule contributing to LPS-tolerance. 
 
FIGURE 1. Smoothed plots of expression of the SOCS-1 gene in relation to endotoxin in children’s 
environment. We related the SOCS-1 gene expression to endotoxin loads in the living room (panel a) 
and mattress (panel b) of children. All values (n=43) were log-transformed and adjusted for age and 
farming. A smoothing span of 0.8 was used for both graphs. The shaded area represents the 95% 
confidence interval. 
Immunological investigations realized in the context of epidemiological studies showed 
that PBL of children living in an environment with elevated amounts of endotoxin secreted 
less inflammatory cytokines upon in vitro re-stimulation with LPS12. We therefore 
investigated whether SOCS-1 levels increased by the exposure to environmental endotoxin 
were sufficient to decrease the responsiveness of PBL to LPS. To assess a possible correlation 
between SOCS-1 expression and LPS-responsiveness in vivo, we stimulated PBL of children 
with LPS in vitro and related the amounts of secreted cytokines to the expression of the 
SOCS-1 gene (Figure 2). The SOCS-1 expression in PBL was inversely related to INF-γ 
release after LPS treatment (correlation coefficient of -0.32, p=0.0415). A tenfold increase in 
expression of the SOCS-1 gene was associated with a 9.9 fold decrease in the concentration of 
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INF-γ (p=0.0369). We observed no statistically significant relationships between SOCS-1 
expression and the secretion of IL-5 and IL-10 (correlation coefficient of -0.07 (p=0.7348) for 
IL-5 and of -0.28 (p=0.7348) for IL-10). Thus, PBL of children living in an environment with 
a higher endotoxin load express higher levels of the SOCS-1 gene. This, in turn, is associated 
with decreased production of INF-γ upon stimulation with LPS in vitro. This can be 
interpreted as LPS-tolerance. 
 
FIGURE 2. Smoothed plots of cytokines secreted upon LPS treatment of whole blood samples in 
relation to the expression of the SOCS-1 gene. We related INF-γ (panel a), IL-5 (panel b), and IL-10 
(panel c) levels in supernatants following LPS stimulation of blood samples to expression of the 
SOCS-1 gene. All values (n=43) were log-transformed and adjusted for age and farming. A smoothing 
span of 0.75 was used for all three graphs. The shaded area represents the 95% confidence interval. 
SOCS-1 knock-out mice had elevated serum IgE levels10. We thus investigated whether 
such a relationship was present in the children of the ALEX study, too. Despite the low 
numbers of samples we could analyze in this study, a trend towards an inverse correlation 
between the expression of the SOCS-1 gene and the IgE level could be observed, although not 
reaching statistical significance. A tenfold increase in the SOCS-1 gene expression was 
associated with a decrease in IgE level by a factor of 3.57 (p=0.1968) (Figure 3). 
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FIGURE 3. Smoothed plot of IgE levels in serum of children in relation to the expression of the 
SOCS1 gene. We related IgE levels in untreated serums of children to the expression of the SOCS1 
gene. All values (n=43) were log-transformed and adjusted for age, farming, and family history of 
asthma or hay fever. A smoothing span of 0.8 was used for the graph. The shaded area represents the 
95% confidence interval. 
In summary, the microbial load in the environment correlates with elevated expression of 
the SOCS-1 gene in children, which, in turn, correlates with lower IgE levels and reduced 
inflammatory responses as shown by decreased levels of INF-γ. We propose that exposure to 
microbes induces inhibitory feedback mechanisms, such as up-regulation of the SOCS-1 
protein. Such regulatory mechanisms of the innate immune system may contribute to the 
protection conferred by exposure to environmental microbes against both Th-2 and Th-1 
associated diseases, i.e. allergic as well as autoimmune disorders. 
Methods 
Sample Collection. The ALEX study was a cross-sectional survey investigating the 
incidence of asthma and allergies in children from rural areas of Austria, Germany, and 
Switzerland. In a subgroup of the Swiss sample (n=43 children), we measured the expression 
of the SOCS-1 gene in peripheral blood leukocytes (PBL), assessed the cytokine production 
by whole blood after ex vivo LPS treatment, and determined the IgE level in serum. 
Measurement of endotoxin (LPS) levels. We collected dust samples in participants’ 
living rooms and mattresses and measured LPS contents using a kinetic limulus assay as 
previously described12. We expressed the amount of LPS in endotoxin units (EU) per square 
meter and designated it as endotoxin load. 
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IgE measurements and cytokine production of blood cells. We stimulated heparinized 
whole blood of children with LPS (10µg/ml) for 24h. Cytokine production and levels of IgE 
were assessed as previously described12. 
SOCS-1 gene expression. We assessed gene expression ex vivo with quantitative real-time 
PCR (TaqMan, Applied Biosytems), without further stimulation of the samples in vitro. The 
total RNA was extracted as described from PBL13. For reverse transcription (RT) we used 
300ng of total RNA in a final volume of 30µl and the TaqMan reverse transcription reagents 
of Applied Biosystems. We performed quantitative real-time PCR with 3µl of RT solution in 
a final volume of 25µl and analyzed it with an ABI Prism 7700 Sequence Detection SystemTM 
(Applied Biosystems). To each reaction we added primers, probe, and 12.5µl TaqMan 
Universal PCR Master MixTM (Applied Biosystems). The primers and probes were designed 
with the primer design software Primer ExpressTM (Applied Biosystem). To measure the 
SOCS-1 gene expression we used the following primer pair: 5'-GCGGAACTGCTTTTTCGC-
3' (200nM) and 5'-ACGCGGATGCTCGTGG-3' (200nM), and a probe with the sequence 5'-
CTTAGCGTGAAGATGGCCTCGGGA-3' (250nM). We related the expression of SOCS-1 
gene to the expression of the endogenous control 18S rRNA determined using the following 
primer pair: 5'-AGTCCCTGCCCTTTGTACACA-3' (200nM) and 5'-
GATCCGAGGGCCTCACTAAAC-3' (200nM), and a probe with the sequence 5'-
CGCCCGTCGCTACTACCGATTGG-3' (250nM). We analyzed the results using the 
standard curve method as described21. For every primer and probe set, we performed control 
experiments assessing background signals by running the reaction without cDNA („no 
template controls“). We did not observe amplification in any of these “no template controls”, 
indicating that there was neither contamination nor unspecific fluorescence. 
Statistical Analysis. We calculated Spearman’s correlation coefficients to examine the 
relationship between expression of the SOCS-1 gene and the level of endotoxin in the 
children’s environment, the amount of cytokines secreted after ex vivo stimulation of whole 
blood with LPS, and the levels of IgE. We log10 transformed all values. We applied linear 
regression models to determine the above relationships adjusted for effect of personal risk 
factors such as sex, age, family history of asthma or hay fever, allergic sensitization and 
farming (SAS 8.2 software). To visualize these associations, SOCS-1 gene expression 
predicted value resulting from a generalized additive regression model using local 
nonparametric smoothing with control for the mentioned covariates was plotted versus 
exposure to environmental endotoxin (S-Plus software). Similarly, we plotted the predicted 
values of cytokine concentrations and IgE levels versus expression of the SOCS-1 gene. The 
final models included farming and statistical significant covariates. 
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Abstract 
Exposure to microbial components protects children against the development of allergic 
disorders. But the protective impact of microbes on children’s immune system is only poorly 
understood. Here we investigated the role of ST2, a molecule crucial in regulating innate and 
T helper cell mediated immune responses, as link between exposure to environmental 
microbes and development of allergies in children of the European cross-sectional 
PARSIFAL study. We found that ST2 expression was decreased if children were exposed to 
microbial components and this, in turn, was associated with reduced T helper cell activation, 
lower IgE levels in serums, and fewer incidences of allergic diseases. Therefore, ST2 is 
crucial participant of the immunological network protecting children against the development 
of allergies in the context of exposure to environmental microbial components. 
Introduction 
Living on a farm protects children against the development of allergic diseases1-3. 
Epidemiological studies observed that especially microbial components such as 
lipopolysaccharides (LPS/endotoxin), an integral part of the outer cell membrane of Gram-
negative bacteria, are abundant in farming environments and are associated with the 
protection of children against allergies4. The innate immune system constitutes the first 
contact to invading microbes and directs the activation of the adaptive immune system via 
induction of co-stimulatory molecules and release of inflammatory cytokines5, 6. Exposure to 
microbial components in environment shapes the innate immune recognition. Farmers’ 
children express more Toll-like receptors (TLR)7, 8. The TLR family constitutes the principal 
receptors for pathogen recognition of the innate immune system9, 10. Furthermore, farming 
lifestyle reduces the ability of children’s blood cells to secrete inflammatory cytokines4. 
To avoid effusive inflammatory responses, diverse molecules tightly control the TLR 
activation pathway11. The expression of some of these regulatory molecules is induced by 
exposure to microbial components leading to a reduced inflammatory response to subsequent 
stimulation12-14. This process is known as endotoxin tolerance15. ST2 has been described as 
such regulator. ST2 (also known as T1, Fit-1, or DER4) is a type I transmembrane protein 
with three extracellular immunoglobulin-like domains and an intracellular TIR 
(Toll/interleukin-1 receptor) domain16, 17. A soluble form of ST2 exists, too. It is generated by 
alternative splicing and is present in normal human serum. ST2-deficient mouse macrophages 
produce elevated amounts of cytokines after stimulation of TLR2, TLR4, and TLR9 but not of 
TLR3. ST2 achieves its inhibitory effects through sequestration of MyD88 (myeloid 
differentiation primary-response protein 88) and TIRAP (TIR-associated protein), two adaptor 
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molecules essential for the activation of the singling cascade of TLR18-20. ST2 is induced in 
macrophages or monocytes after stimulating with TLR4 ligand LPS or with inflammatory 
cytokines for 4 hours in vitro, turning ST2 into a negative feedback inhibitor necessary for 
endotoxin tolerance20, 21. 
Soluble ST2 is enhanced in serum of patients with inflammatory diseases like asthma but 
also of autoimmunity indicating an influence of ST2 on T helper cell differentiation22-24. T 
helper cells differentiate into T helper cell type 1 (Th-1), Th-2, or T regulatory cells (Treg) 
depending on the cytokines present. Th-1 response is associated with autoimmunity, Th-2 
with allergic diseases, Treg with a silencing of Th-1 and Th-2 responses25, 26. ST2 has an 
important role in Th-2 effector function and interleukin (IL)-33, a ligand of ST2, induces Th-2 
associated cytokine secretion27-30. Furthermore, expression of the ST2 gene is regulated by the 
Th-2 transcription factor GATA-331.  
The functions attributed to ST2, negative feedback inhibitor of the innate immune system 
and its role in boosting Th-2 responses, are an immunological contradiction. LPS tolerance is 
associated with reduced risk to develop allergies, while Th-2 cells promote these diseases. 
Therefore, we investigated the role of ST2 in children. We assessed the expression of the 
human ST2 gene in blood leukocytes of children living in areas with various endotoxin levels. 
Furthermore, we correlated the expression of ST2 gene with the gene expression of markers 
of T helper cells, with the amount of IgE in serum and with allergic symptoms of children. 
We found that the expression of the ST2 gene was reduced in children exposed to high levels 
of endotoxin. Furthermore, the ST2 gene expression was associated with the expression Th-1, 
Th-2, and Treg cells marker genes. The expression of the ST2 gene was also induced in 
children with elevated levels of IgE in serum and in children suffering from allergic diseases. 
Methods 
Population and questionnaires. We assessed gene expression of ST2 and T helper cell 
markers in the Swiss branch of the PARSIFAL study32. RNA samples were collected from 
195 farm and 127 reference children (95.3% of children who provided blood samples) to 
analyze gene expression in their blood leukocytes8. The questions on health outcomes were 
derived from the internationally validated International Study of Asthma and Allergies in 
Childhood II33 questionnaire and the Allergy and Endotoxin study34, respectively. We 
considered children who had a doctor’s diagnosis of asthma and hay fever8. 
Measurement of total and allergen-specific serum IgE levels. Total and allergen-
specific IgE for common inhalant (Phadiatop) and food allergens (fx5; Pharmacia CAP 
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System; Pharmacia Diagnostics AB) was measured in serum. We used for atopic sensitization 
a cut-off value of 0.35 kU/L or greater8. 
Measurement of IgG, IgA, and IgM serum levels. The serum levels of IgG, IgA, and 
IgM of children were determined by nephelometric measurements using the Beckman Array® 
360 System with the Beckman Reagent Test Packs (Beckman Coulter). 
Measurement of endotoxin. Endotoxin was measured in dust samples of mattresses of 
83.9% of children with complete gene expression data (n = 270) with the kinetic chromogenic 
Limulus Amebocyte Lysate test (Bio Whittaker) and expressed as amount of endotoxin per 
gram dust8, 35. 
RT-PCR and quantitative real-time PCR (TaqMan®). The total RNA was isolated as 
described8 and stored at minus 80°C. For reverse transcription (RT) of RNA we used 300ng 
of total RNA in a final volume of 30µl and added adequate amounts of TaqMan® Reverse 
Transcription Reagents (Applied Biosystems). Quantitative real-time PCR was performed on 
an ABI Prism 7900 Sequence Detection System (Applied Biosystems) using the TaqMan® 
low density array (LDA) system of Applied Biosystems. The determined gene expression 
values were normalized to the parallel measured endogenous control 18S rRNA. We analyzed 
the data with the comparative Ct method according to the manufacturer’s instructions 
(Applied Biosystem). 
Results 
To investigate whether ST2 is involved in mediating endotoxin tolerance in vivo, we 
assessed the expression of the ST2 gene in blood leukocytes of children of a Swiss subsample 
of the PARSIFAL (Prevention of Allergy Risk factors for Sensitization In children related to 
Farming and Anthroposophic Lifestyle) study by quantitative real-time PCR32. Furthermore, 
we measured the endotoxin concentration in dust samples collected of children’s mattresses. 
We found negative correlations between endotoxin in mattress and the expression of the ST2 
gene (Geometric mean ration: 0.56 (p<0.01) of the 2. tertile related to the 1. tertile; 0.78 
(p>0.1) of the 3. tertile related to the 1. tertile).  
Next, we investigated an association of the ST2 expression with T helper cell 
differentiation. We related the expression of the ST2 gene to the gene expression of T cell 
transcription factors T-bet, GATA-3, and FOXP3 measured by quantitative real-time PCR. 
Each transcription factor is specific for a T cell phenotype: T-bet for Th-1, GATA-3 for Th-2, 
and FOXP3 for Treg cells. We observed positive associations between the expression of the 
ST2 gene and the expression of all T cell transcription factor genes (Figure 1). 
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FIGURE 1. Expression of T helper cell marker genes related to the expression the ST2 gene in 
children’s blood leukocytes. We related the expression of the T-bet (white bar), the GATA-3 (grey 
bar), and the FOXP3 (black bar) gene to the expression of the ST2 gene. Measure of effect size: 
geometric means rations and 95% confidence intervals; all estimates adjusted for farming status, sex, 
age, and parental history of atopy; *: 0.05 > p > 0.01, **: p < 0.01. 
Since soluble ST2 serum levels were enhanced in patients with asthma, we assessed a 
correlation between the expression of the ST2 gene in children’s blood leukocytes and total 
immunoglobulin levels in serums. Furthermore, we related the expression of the ST2 gene to 
the level of specific IgE directed against common inhalant and food allergens and to the 
incidence of allergic health symptoms of children (Table 1). We found that the ST2 gene 
expression correlated with enhanced total and allergen-specific IgE serum levels, while there 
was no association between the expression of the ST2 gene and levels of IgM, IgA, and IgG. 
Furthermore, the ST2 gene expression correlated with the incidence of asthma and hay fever 
symptoms in children. 
 
Ig/allergic disease Odds ratios
total IgM 1.07 (0.48-2.39)
total IgA 1.03 (0.52-2.05)
total IgG 0.99 (0.93-1-06)
total IgE 1.25 (1.13-1.38)**
specific IgE 1.49 (1.2-1.84)**
asthma 1.48 (1.05-2.1)*
hay fever 1.59 (1.06-2.37)*
TABLE 1. Association between ST2 gene expression and Ig 
serum levels, asthma and hay fever symptoms
Values for total IgM, IgA, IgG, IgE geometric means ratios, for 
specific IgE, asthma, hay fever odds ratios and 95% confidence 
intervals; adjusted for farming status, sex, age, and parental history 
of atopy; *: 0.05 > p > 0.01, **: p < 0.01
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Discussion 
Living of children in areas with elevated levels of microbial components in the 
environment was associated with reduced expression of ST2. This, in turn, correlated with 
reduced levels of T helper cells, lower levels of IgE, and less incidence of allergic disorders. 
Therefore, ST2 represents another immunological mechanism, how exposure to microbes in 
the environment protects children against the development of allergies. 
A role of ST2 in mediating endotoxin tolerance in children via negative regulation of the 
TLR signaling cascade is implausible, because such a regulator has to be induced through 
exposure to environmental microbial components as we found it for the suppressor of 
cytokine signaling (SOCS)-1 protein. It seems that ST2, up-regulated shortly after 
administration of bacterial components, may regulate TLR signaling cascade in an early 
phase20, 21. Chronic exposure to microbes, as it was the case for the children of our study, 
reduced the ST2 expression. The observation that ST2-deficient mice were no more 
susceptible to LPS shock than wild-type mice, make a role of ST2 in mediating endotoxin 
tolerance more implausible11, 20. Nevertheless, our experimental setup failed to fully proof this 
hypothesis, since we did not perform re-stimulation experiments to assess the responsiveness 
of children’s white blood cells. 
ST2 was involved in non-phenotype specific T helper cell activation as shown by positive 
correlations between ST2 expression and the expression of T helper cell transcription factors. 
These results stand in contrast to observations that ST2 selectively promotes Th-2 
differentiation. But our findings were supported by studies describing enhanced ST2 levels in 
patients suffering from Th-1 associated autoimmune diseases as well as from Th-2 associated 
allergic diseases22-24. 
The hygiene hypothesis was emerged after epidemiological studies observed an association 
between improved hygienic conditions of western countries and the increased incidence of 
allergic and autoimmune diseases36. Besides of the SOCS-1 protein, ST2 is already the second 
molecule, we described to be a participant in the network constituting the immunological 
basis of hygiene hypothesis although the functions of these molecules are different. The 
SOCS-1 protein mediates protection against allergies and autoimmunity of children via 
regulating the innate immune response, while ST2 seems to be involved in regulation of T 
helper cell activity. 
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Introductory paragraph 
Major histocompatibility complex (MHC) class II molecules play crucial roles in immune 
activation by presenting foreign peptides to antigen-specific T helper cells and thereby 
inducing adaptive immune responses. Although adaptive immunity is a highly effective 
defense system, it takes several days to become fully operational and needs to be triggered by 
danger-signals generated during the preceding innate immune response. Toll-like receptors 
(TLR) recognize conserved molecular patterns of microbes, initiate rapid anti-microbial 
responses protecting the host during the fist days of infection1, 2, and generate danger-signals 
required for activation of the adaptive immune system3. A role of MHC class II molecules in 
initiating innate immune responses has so far not been documented. Here we show that MHC 
class II molecules synergize with TLR2 in inducing an innate immune response. We found 
that co-expression of MHC class II molecules and TLR2 leads to enhanced production of the 
anti-microbial peptide human β-defensin-2 and increased activation of the transcription factor 
NF-κB after treatment with bacterial lipoproteins. Furthermore, we show that MHC class II 
molecules are physically associated with TLR2 in lipid raft domains of the cell membrane. 
These results demonstrate that MHC class II molecules are, in addition to their central role in 
adaptive immunity, also implicated in generating optimal innate immune responses. 
Results and Discussion 
To assess a potential role of MHC class II molecules in the innate immune response we 
compared expression of the antimicrobial peptide human β-defensin (hBD)-2 in transfected 
cells differing only with respect to their expression of HLA-DR, which is the most abundant 
MHC class II molecule. The human embryonic kidney (HEK) 293 cell line expresses neither 
MHC class II molecules nor TLR2, as judged by flow cytometry. These cells were transfected 
stably with TLR2 and/or HLA-DR1, stimulated with the synthetic TLR2-ligand bacterial 
lipoprotein (Pam3CysSKKKK, sBLP), and assessed by quantitative real-time PCR for their 
expression of the hBD-2 gene (Figure 1a). In agreement with previous reports4, 5, expression 
of TLR2 alone led to an increase in hBD-2 production, however, only a slight one. Expression 
of HLA-DR1 together with TLR2 markedly enhanced production of the antimicrobial peptide. 
Expression of HLA-DR1 alone was not sufficient to confer responsiveness to sBLP. 
TLR-triggered cellular responses generally involve NF-κB activation2. We therefore, 
examined whether NF-κB was involved in the enhancement of the innate immune response 
observed in cells co-expressing TLR2 and HLA-DR1. Using a NF-κB-sensitive reporter 
plasmid as the readout system we found that NF-κB activation paralleled the induction of 
hBD-2 expression, except that HLA-DR1 alone supported a low level of sBLP-independent 
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NF-κB activity (Figure 1b). Moreover, the induction of hBD-2 by sBLP through TLR2/HLA-
DR1 was down regulated in a dose-dependent manner by the NF-κB inhibitor peptide NBD 
(Figure 1c). The expression of HLA-DR1 together with TLR2, therefore, augments TLR2-
ligand triggered, NF-κB-mediated cellular activation. 
 
FIGURE 1. Expression of HLA-DR1 enhances TLR2 dependent activation of HEK293 cells. (A,B) 
Co-expression of HLA-DR1 in TLR2+ HEK293 cells leads to enhanced hBD-2 expression (n=5) and 
NF-κB activity (n=3) after stimulation with sBLP (black bars) compared to untreated cells (white 
bars). (C) The NBD peptide inhibits NF-κB mediated hBD-2 expression after stimulation with sBLP 
in TLR2+ (grey bars) and TLR2+/HLA-DR1+ (black bars) HEK293 cells (n=3). Error bars represent 
standard errors. 
Next, we evaluated the contribution of MHC class II molecules to innate immune response 
in another experimental model. Since the expression of inducible NO synthase (iNOS) has 
been reported to be induced by TLR2 engagement in mice6, we compared expression of the 
iNOS gene in lung tissues isolated from wild type (wt) and MHC class II knock-out (ko) mice 
of the same genetic background (C57BL/6) following treatment with sBLP7. The response of 
the MHC class II ko tissue was markedly reduced compared to that of the wild-type tissue 
(Figure 2). This ex vivo system, thus, reproduces the results obtained with the HEK293 cells. 
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FIGURE 2. Lung tissues from MHC class II ko mice exhibit impaired responsiveness to sBLP. 
Inducible NO synthase mRNA expression in lung tissue from MHC class II knock-out mice (grey 
curve; n=5) and wt control mice (black curve; n=5) after ex vivo stimulation with sBLP. Error bars 
represent standard errors. 
We then assessed whether the functional synergism between TLR2 and MHC class II 
molecules might involve their physical interaction. We found that recombinant radioactively 
labeled TLR2 can be co-precipitated with HLA-DR1 (Figure 3). MHC class II molecules are 
localized in lipid raft domains of the cell membrane and these membrane domains are 
essential for efficient signaling processes8-11. A role for lipid rafts in TLR-signaling has 
previously been reported for TLR412. We found that methyl-β-cyclodextrin (MCD) mediated 
destruction of lipid raft domains inhibited sBLP-triggered expression of the hBD-2 gene in a 
dose dependent manner in HLA-DR1+/TLR2+ cells (Figure 4). Moreover, 
immunofluorescence microscopy revealed that HLA-DR1 and TLR2 co-localize in lipid raft 
domains (Figure 5). 
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FIGURE 3. TLR2 and HLA-DR1 interact physically. Co-precipitation of labeled recombinant TLR2 
(lane 1, 3, 4) or a control protein (lane 2, luciferase) with HLA-DR1 molecules purified by 
immunoprecipitation with anti HLA-DR antibodies (lane 1, 2, 4) or control antibodies (lane 3) from 
cell lysates of HLA-DR1 positive (lane 1, 2, 3) or negative (lane 4) HEK293 cells. A 14C-labeled 
molecular weight marker (in kD) is shown in the left lane. 
Our results reveal a highly novel and unexpected function of MHC class II molecules. We 
show here that MHC class II molecules can play a key role in innate immunity by enhancing 
TLR-mediated cellular activation. The induction of MHC class II expression by TLR 
agonists13, 14, thus, not only enables effective antigen presentation for the activation of 
adaptive immunity, but also functions as a positive feedback mechanism that enhances TLR-
mediated responses. The innate immune response is a tightly regulated process involving 
numerous stimulatory and inhibitory molecules15. Over-reaction of the innate immune system 
may lead to chronic inflammation, allergy, and autoimmunity. Insufficient activation results 
in both inadequate protection during the first days of infection and in inefficient or 
inappropriate activation of the adaptive immune system, potentially leading to disease or 
death. We have identified MHC class II molecules as novel participants in the complex 
regulatory mechanisms that control the efficiency of innate immune responses. 
 74 
 
FIGURE 4. Enhanced responsiveness of HLA-DR1+/TLR2+ HEK293 cells is dependent on lipid raft 
domains. Treatment of TLR2+ (grey bars; n=3) or HLA-DR1+/TLR2+ (black bars; n=3) HEK293 cells 
with MCD, a lipid raft-destroying agent, prior to stimulation with sBLP leads to impaired hBD-2 gene 
expression. Error bars represent standard errors. 
 
FIGURE 5. TLR2 and MHC class II molecules co-localize in lipid raft domains. Immunofluorescence 
microscopy was used to show that TLR2 (αTLR2-FITC; green) and HLA-DR1 (αHLA-DR-APC-
Cy9; blue) co-localize in lipid raft domains (CT-rhodamine; red) of HLA-DR1+/TLR2+ HEK293 cells 
(indicated by the white arrows). Pictures are representatives of at least five experiments. 
Methods 
Cell lines and media. The human embryonic kidney cell line (HEK293) was obtained 
from the American Type Collection Culture (ATCC). HEK293 cells transfected with HLA-
DR1 (α-, β-, and invariant chain) were a gift from Dr. J. Neffjes (Netherlands Cancer 
Institute). These cells were stably transfected with an empty pCEP4 plasmid (Invitrogen) or a 
pUNO-hTLR2 plasmid (InvivoGen) using the TransIT-293 Transfection Reagents (Mirus). 
Cells were grown in DMEM (Gibco BRL) supplemented with 10% low endotoxin FBS 
(Hyclone) and 1% of an antibiotic-antimycotic solution (Gibco BRL). Depending on the 
resistance genes present, medium was supplemented with the additional selection antibiotics 
G418, Hygromycin (Roche Diagnostics), Ovabain (Sigma), or Blasticidin (InvivoGen). 
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NF-κB reporter gene assay. Cells were seeded in 6-well plates (2x105 cells/well) and 
incubated at 37°C in 5% CO2. When at least 80% confluent, cells were transfected with pNF-
κB-Luc (NF-κB dependent luciferase reporter plasmid, 1.25µg/ml, Clonetech) and pCMV-
lacZ (CMV-promoter controlled β-galactosidase plasmid, 0.6µg/ml, a gift from Dr. J.-P. 
Hossle, Zürich, Switzerland) using TransFectin Lipid Reagent (BioRad). 48h after 
transfection the cells were stimulated for 6h with synthetic bacterial lipoprotein (1µg/ml, 
sBLP, Pam3Cys-SKKKK, EMC microcollections). After cell lysis, luciferase activity was 
measured in counts per minute (CPM) using a luciferase assay system (Promega) and a TD-
20/20 Luminometer (Turner designs). Values were corrected for transfection efficiencies 
(divided by the lacZ-activity determined as the absorption at 420nm). 
Cell stimulation and total RNA extraction. Cells were grown in 6-well plates at 37°C in 
5% CO2 until they were 80% confluent, and then stimulated for 6h with sBLP (1µg/ml) or 
sBLP in combination with various concentrations of the NBD peptide (Alexis Biochemicals) 
or Methyl-β-cyclodextrin (MCD, Sigma-Aldrich). NBD peptide or MCD were added 30 or 10 
minutes before sBLP, respectively. The QIAmp RNA Blood Mini Kit (Qiagen) supplemented 
with RNase-free DNase (Qiagen) was used for total RNA isolation. 
Ex vivo mouse experiments. Experiments were performed with wild type (Harlan) and 
MHC class II deficient7 C57BL/6 mice. Lung tissues were stimulated for 4h with 10µg/ml 
sBLP in RPMI 1640 (Gibco BRL) containing 10% FBS. Tissues were homogenized using a 
rotor-stator tissue homogenizer and total RNA was isolated with the QIAmp RNA Blood 
Mini Kit (Qiagen) according to the manufacturer’s instructions. 
Quantitative real-time PCR. Reverse transcription and quantitative real-time PCR were 
performed with reagents from Applied Biosystems according to the manufacturer’s 
instructions. Quantitative real-time PCR was performed with an ABI Prism 7700 Sequence 
Detection SystemTM (Applied Biosystems). For hBD-2 mRNA, primers were 5'-
GAGGAGGCCAAGAAGCTGC-3' (300nM) and 5'-CGCACGTCTCTGATGAGGG-3' 
(300nM), and the probe was 5'-TGGCTGATGCGGATTCAGAAAGGG-3' (250nM). For 18S 
rRNA primers were 5'-AGTCCCTGCCCTTTGTACACA-3' (200nM) and 5'-
GATCCGAGGGCCTCACTAAAC-3' (200nM), and the probe was 5'-
CGCCCGTCGCTACTACCGATTGG-3' (250nM). All oligonucleotides were synthesized by 
Microsynth. A pre-developed assay (Applied Biosystems; Mm00440485_m1) was used to 
measure expression of the inducible nitric oxide synthase gene. Results were normalized 
relative to 18S rRNA using the Comparative (ΔΔCt) method according to the manufacturer’s 
instructions (Applied Biosystems). 
Co-immunoprecipitations. Immunoprecipitations were performed using the ‘Cellular 
Labelling and Immuoprecipitation Kit’ according to the manufacturer’s instructions (Roche 
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Diagnostics). HEK293 cells were collected in lysis buffer, sonificated, and insoluble material 
was removed by centrifugation. To eliminate non-specific binding, supernatants were 
incubated with 50µl protein A agarose and cleared by centrifugation. Immunoprecipitation 
was then performed by mixing 1µg of unlabeled anti-HLA-DR1 antibodies with 40µl of the 
pre-cleared supernatant and 50µl protein A-agarose. The immunoprecipitates were collected 
by centrifugation, washed and dissolved in 50mM TBS (pH 7.5). Recombinant radio-labelled 
proteins were synthesized using the TNT T7 Quick Coupled Transcription/Translation System 
(Promega) and pBluescript KS (-) plasmids expressing TLR2 or luciferase. The recombinant 
molecules were added to the immunoprecipitated samples and complexes were collected by 
centrifugation, washed, and analyzed by SDS-PAGE.  
Immunofluorescence microscopy. HEK293 cells expressing HLA-DR1 and TLR2 were 
grown overnight on coverslips and fixed for 15 min. with 3% paraformaldehyde. Cells were 
stained by sequential 45 min. incubations with rhodamin-labelled cholera toxin Β subunit 
(0.5µg/ml; List Biological Laboratories) to visualize the lipid raft domains, a FITC anti-
human TLR2 monoclonal antibody (T2.1; eBioscience), and an APC-Cy9 anti-human HLA-
DR monoclonal antibody (L243; BD Biosciences). Cells were washed three times with PBS 
between each staining step. Cells were mounted in Glycergel (DakoCytomation) and observed 
with a Leica TCS SL confocal microscope using the 63x/1.2 W CORR PL APO objective 
(Leica). 
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Abstract 
BACKGROUND: There is increasing evidence that environmental exposures determining 
childhood illnesses operate early in life. Prenatal exposure to a farming environment through 
the mother might also play an important role. OBJECTIVE: We sought to investigate the role 
of maternal exposures to environments rich in microbial compounds for the development of 
atopic sensitization, asthma, and corresponding alterations in the innate immune system in 
offspring. METHODS: In the children of the cross-sectional Prevention of Allergy Risk 
Factors for Sensitization in Children Related to Farming and Anthroposophic Life Style 
study, asthma and atopy were assessed by means of standardized questionnaires (n = 8263) 
and serum IgE measurements (n = 2086). In a subsample (n = 322) gene expression of Toll-
like receptors (TLR2 and TLR4) and CD14 was assessed. Maternal exposures were defined 
through questionnaire information. RESULTS: Both atopic sensitization (adjusted odds ratio, 
0.58; 95% CI, 0.39-0.86) and the gene expression of receptors of innate immunity were 
strongly determined by maternal exposure to stables during pregnancy, whereas current 
exposures had much weaker or no effects. A dose-response relation was found between the 
extent of upregulation of these genes and the number of different farm animal species the 
mother had encountered in her pregnancy. Each additional farm animal species increased the 
expression of TLR2, TLR4, and CD14 by a factor of 1.16 (95% CI, 1.07-1.26), 1.12 (95% CI, 
1.04-1.2), and 1.10 (95% CI, 1.03-1.23), respectively. CONCLUSION: Maternal exposure to 
an environment rich in microbial compounds might protect against the development of atopic 
sensitization and lead to upregulation of receptors of the innate immune system. The 
underlying mechanisms potentially operating through the intrauterine milieu or epigenetic 
inheritance await further elucidation. CLINICAL IMPLICATIONS: When assessing risk 
factors of allergies in an infant's medical history, attention must also be paid to environmental 
exposures affecting the mother. 
Introduction 
Childhood asthma and allergies manifest in the first years of life1, 2. Environmental 
exposures implicated in the inception of these illnesses must therefore occur even earlier (ie, 
before the manifestation of the first symptoms). In recent years, a number of studies have 
shown that exposures in the first 12 to 24 months of life might indeed determine the 
development of childhood asthma and allergies1, 3-5. The temporal sequence of events might, 
however, be traced back to prenatal exposures, namely exposures of the mother. Active 
smoking during pregnancy6; exposure of the pregnant mother to antibiotics7, paracetamol8, 
and allergens9, 10; and the effect of such exposure on the fetus have been investigated in some 
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detail. Still, little is known about the effects of maternal exposure to microbial compounds in 
the environment on the development of atopy and asthma in offspring. 
A deviated humoral immune response resulting in the production of IgE rather than IgG 
antibodies is the common feature of atopic diseases. The regulation of the humoral response 
by B cells depends on T effector cells. In turn, T-cell function is regulated by mediators of the 
innate immune system. Although it has been shown that adaptive immune responses can be 
shaped in utero11, little is known about potential prenatal determinants of the innate immune 
response and its relation to the development of atopy and asthma. 
The aim of the present study was to investigate the role of exposures of the mother and the 
child, respectively, to environments rich in microbial burden for the development of atopy 
and asthma, as well as the gene expression of receptors of the innate immune response in the 
offspring. 
Methods 
Population and study areas. The cross-sectional Prevention of Allergy Risk Factors for 
Sensitization in Children Related to Farming and Anthroposophic Life Style (PARSIFAL) 
study aimed at studying the determinants of childhood asthma and allergies in farming and 
anthroposophic populations, as described previously12. A child who lived on a farm and 
whose family ran the farm was considered a farm child. Other children were termed farm 
reference children. The present analyses focus on 2823 farm and 5440 farm reference children 
aged 5 to 13 years from rural areas of Austria, Germany, the Netherlands, Sweden, and 
Switzerland. In Sweden farmers with children were identified from the Farming Registry at 
the National Bureau of Statistics, and farm reference children were randomly selected from 
the population registry among children living in the same area. In Austria all farm children of 
a given school class were chosen by teachers who had a good knowledge of the region, and 
reference children were randomly selected from the same schools by the local study group. In 
the other countries children were randomly selected from schools in areas known to have a 
high percentage of farmers. 
The study was approved by the ethical boards of the 5 study centers, and written informed 
consent was obtained from the children's parents or guardians for questionnaires, blood 
sampling, and genetic analyses. 
Questionnaires. The questionnaire comprised questions on sociodemographic 
background, parents' atopic diseases, family, and housing characteristics. In addition, 
information on the child's farm activities, as well as the mother's farm exposures during 
pregnancy, were available. Questions related to the child's contact with different farm animals 
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(during the first year of life or later), consumption of farm milk (during the first year of life or 
current), and regular stable or barn visits and helping with haying at present. Activities 
occurring at least weekly were defined as occurring regularly. Maternal exposure included 
contact to different farm animal species during pregnancy and regularly working in stables 
(sheep shelters, hog, cow, and chicken houses) during pregnancy and lactation. The 
questionnaire asked for contact with 6 different farm animal species (cows, pigs, sheep, 
horses, goats, and poultry), and these were summed. 
Questions on health outcomes and farm exposures were derived from the internationally 
validated International Study of Asthma and Allergies in Childhood II13 questionnaire and the 
Allergy and Endotoxin study14, respectively. Children were considered to have current 
rhinoconjunctivitis symptoms if sneezing, runny nose, stuffy nose, and itchy eyes were 
reported in the last 12 months without the child having a cold at the same time. Current 
wheezing was defined as at least one episode of wheezing during the last 12 months. Children 
reported to have had symptoms of seasonal rhinoconjunctivitis in the last 12 months were 
defined as symptomatic, whereas children with a report of a physician's diagnosis of hay fever 
were considered to have a physician's diagnosis of seasonal rhinoconjunctivitis. Children with 
a report of a physician's diagnosis of asthma or of obstructive bronchitis more than once in 
their lifetime were considered to have a physician's diagnosis of asthma. 
Measurement of allergen-specific serum IgE levels. In Austria, the Netherlands, and 
Sweden all children whose parents had consented to blood sampling were invited to a 
physical examination with blood sampling. In Germany and Switzerland only a random 
sample of those who consented were invited because of the comparatively large number of 
children included in these countries12. This subsample of children with blood analysis (n = 
2086) did not significantly differ from the whole sample in regard to disease frequencies or 
family history of atopic disease (data not shown). 
Allergen-specific IgE for common inhalant (Phadiatop) and food allergens (fx5; Pharmacia 
CAP System; Pharmacia Diagnostics AB, Uppsala, Sweden) was measured in serum. Two 
cut-off values for atopic sensitization were used: IgE values of 0.35 kU/L or greater and 3.5 
kU/L or greater for either inhalant or food allergens. 
Expression of Toll-like receptors. For the Swiss branch of the PARSIFAL study, RNA 
samples were collected from 195 farm and 127 reference children (95.3% of children who 
provided blood samples) to analyze gene expression of innate immunity receptors. Children 
with available RNA samples did not differ significantly from the total Swiss PARSIFAL 
population with respect to farm exposures and health outcomes (data not shown). 
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The total RNA was isolated with the QIAmp RNA Blood Mini Kit (Qiagen, Hilden, 
Germany) supplemented with RNase-free DNase (Qiagen). Quantitative real-time PCR 
(TaqMan; Applied Biosystems, Foster City, Calif) was performed, as described elsewhere15. 
In brief, primers and probes were designed by using the primer design software Primer 
Express (Applied Biosystems). Optimal concentrations for primers and probes were 
determined according to the manufacturer's instructions. The reactions for the target and the 
endogenous control were performed in separate tubes. All PCR reactions were analyzed on an 
ABI Prism 7700 Sequence Detection System (Applied Biosystems). Experiments assessing 
background signals were performed for every assay by running the reaction without templates 
(“no template controls”). No amplification was observed in any of these “no template 
controls,” indicating that there was neither contamination nor unspecific fluorescence (see Fig 
E1 in the Online Repository at www.jacionline.org). The data are presented as normalized 
values (the amount of mRNA of the target molecule divided by the amount of mRNA of the 
endogenous control [18s rRNA]). 
Measurement of endotoxin and extracellular polysaccharide in dust samples. 
Endotoxin and fungal extracellular polysaccharide (EPS) were measured in mattress dust 
samples of 83.9% of children with complete gene expression data (n = 270). Sampling and 
detection methods are described elsewhere16. In brief, endotoxin was measured with the 
kinetic chromogenic Limulus Amebocyte Lysate test (Bio Whittaker, Walkersville, Md) and 
EPS with a specific sandwich enzyme immunoassay for EPS of Aspergillus and Penicillium 
species17. 
Statistical analysis. Statistical analysis was performed with SAS 9.1.3 (The SAS Institute, 
Cary, NC) and Stata/SE 8.2 (StataCorp LP, College Station, Tex) software. Odds ratios (ORs) 
or geometric means ratios and 95% CIs were calculated in multiple logistic regression 
analysis. 
In preliminary logistic analyses the associations of atopic sensitization, atopic symptoms, 
or diseases and exposure to farm characteristics were explored and adjusted for predefined 
covariates (age, sex, parental education, maternal and paternal atopy, number of older 
siblings, exposure to pets, and study center). We included farm characteristics that best 
predicted being a farm child, namely the child's current exposure to a farming lifestyle 
(regular stable or barn visits or helping with haying), the child's exposure to farm animals 
(ever), predominant consumption of farm milk (ever), and regular maternal work in stables 
during pregnancy. In the final regression model all variables were mutually adjusted. The 
independent effects of maternal work in stables during pregnancy and lactation were 
investigated to evaluate the effect of timing of the exposure. 
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Because the distribution of gene expression levels of the CD14, Toll-like receptor (TLR) 2, 
and TLR4 genes was skewed, these variables were log-transformed, resulting in a good 
approximation to the normal distribution (data not shown). For farm and farm reference 
children, these log-transformed values were compared by using the t test, and crude geometric 
means with their 95% CIs were computed. Multiple regression models adjusting for the same 
covariates as mentioned above were used to explore the associations between gene 
expressions and farm-related exposure measures. Results were expressed as adjusted 
geometric means ratios. In addition, adjusted geometric means of normalized gene expression 
were calculated for different levels of specific exposure variables (eg, the number of farm 
animal species the mother was exposed to during pregnancy). 
In further analyses the effect of additional exposures during intervening years (5-13 years) 
that might influence atopic sensitization or gene expression were tested. In turn, the following 
variables were included in the regression models: worm infestations ever, respiratory 
infections during the first 2 years of life, day-care attendance, prescription of antibiotics or 
antipyretics before or after the first year of life, and history of measles, rubella, mumps, 
pertussis, or mononucleosis. 
Results 
Of the 11,969 invited farm and farm reference children, 8402 (70%) returned the 
questionnaires. A total of 139 children were excluded because of missing values for sex and 
age or because they did not meet the age criteria of 5 to 13 years. 
The prevalence of all outcomes (atopic sensitization, rhinoconjunctivitis symptoms and 
physician's diagnosis of seasonal rhinoconjunctivitis, and current wheezing and physician's 
diagnosis of asthma) was significantly lower in farm children compared with in nonfarm 
children (see Fig E2 in the Online Repository at www.jacionline.org)12, despite some 
heterogeneity across the countries. The most pronounced differences between farm and 
nonfarm children were seen in Germany. 
Factors mediating the farm effect 
Determinants of the protective farm effect were assessed in multiple regression models 
(Table 1). Predominant farm milk consumption was inversely related to the symptoms (P = 
.079) and diagnosis of seasonal rhinoconjunctivitis (P = .022), asthma (P = .038), and 
wheezing (P = .065). Additionally, regular contact with farm animals contributed to the 
protective effect on the physician's diagnosis of seasonal rhinoconjunctivitis (P = .049). 
Rhinoconjunctivitis symptoms in the last 12 months were also inversely related to frequent 
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stable or barn visits or help with haying (P = .007). The strongest protective effect, however, 
was found for maternal stable work during pregnancy on atopic sensitization (OR, 0.58; 95% 
CI, 0.39-0.86; P = .007). Moreover, this association remained significant after additional 
adjustment for being a farm child or correction for multiple testing (PBonferroni = .035). 
 
Maternal stable exposure during pregnancy versus lactation 
Because 20% of all mothers working in the stable during pregnancy (n = 2184) stopped 
working in the stable after giving birth to the child, it was possible to disentangle the 
contributions of pregnancy and lactation, respectively, to the maternal effect. The effect of 
maternal stable work during lactation tended to be less pronounced (OR, 0.66; 95% CI, 0.45-
0.96). It was no longer statistically significant when adjusted for maternal exposure in 
pregnancy (OR, 0.92; 95% CI, 0.52-1.61). When assessing the effect of timing of first 
exposure to farm animals on atopic sensitization, adjusted ORs for first contact in pregnancy, 
first contact in first year of life, first contact between first year and current, and current first 
contact were 0.36 (95% CI, 0.25-0.51), 0.54 (95% CI, 0.32-0.92), 0.77 (95% CI, 0.49-1.22), 
and 0.71 (95% CI, 0.43-1.20), respectively. 
Variation of the effect on atopic sensitization across countries 
We furthermore assessed the effect of maternal stable work during pregnancy on atopic 
sensitization for each country separately (Figure 1). The protective maternal effect was found 
in all countries but Sweden (OR, 1.41; 95% CI, 0.50-4.01). We investigated different cut-off 
definitions in the 4 countries showing a protective maternal effect. Using the detection limit 
as cut-off (≥0.35 kU/L) yielded a somewhat weaker but still significant effect (OR, 0.73; 
(95% CI, 0.54-0.995) compared with a cut-off level of 3.5 kU/L or greater (OR, 0.53; 95% 
CI, 0.35-0.80). 
TABLE 1. Mutually adjusted ORs for associations of farm-related exposures with health outcomes 
Atopic sensitization  
(! 3.5 kU/L)
Rhinoconjunctivitis 
symptoms
Physician’s diagnosis of 
rhinoconjunctivitis
Wheezing Diagnosis of asthma
(n=285/2086) (n=507/8174) (n=343/8130) (n=552/8169) (n=656/8080)
0.96 (0.63-1.46) 0.63 (0.45-0.88) 0.66 (0.41-1.07) 0.88 (0.65-1.19) 0.82 (0.62-1.09)
p=0.854 p=0.007 p=0.090 p=0.403 p=0.172
0.76 (0.51-1.15) 0.87 (0.67-1.14) 0.69 (0.47-1.00) 0.97 (0.75-1.26) 0.94 (0.75-1.19)
p=0.194 p=0.321 p=0.049 p=0.822 p=0.629
0.76 (0.52-1.11) 0.77 (0.58-1.03) 0.63 (0.42-0.93) 0.77 (0.58-1.02) 0.76 (0.59-0.99)
p=0162 p=0.079 p=0.022 p=0.065 p=0.038
0.58 (0.39-0.86) 0.74 (0.50-1.09) 0.77 (0.44-1.36) 0.76 (0.54-1.07) 0.86 (0.63-1.16)
p=0.007 p=0.126 p=0.371 p=0.120 p=0.325
*"Current regular exposure to stable or barn or regular participation in haying.
†"Mother worked regularly in stable during pregnancy.
ORs are given with 95% CIs in parentheses and P values. The models are adjusted for age, sex, family history of atopy, parental education, environmental 
tobacco smoking, maternal smoking during pregnancy, number of older siblings, contact with pets ever, 
Current farm 
exposure*
Regular contact to 
farm animals ever
Farm milk 
consumption ever
Stable exposure in 
pregnancy†
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FIGURE 1. Adjusted ORs for maternal work in stables during pregnancy on atopic sensitization across 
countries. As a cut-off point for atopic sensitization, a value of 3.5 kU/L or greater was used. The ORs 
are given separately for the following countries: Austria (AT), Germany (GE), the Netherlands (NL), 
Switzerland (CH), and Sweden (SE). 
Association of farm-related exposure with gene expression 
Because environmental factors have been shown to correlate with the expression of 
receptors of the innate immune system, we next investigated the expression of the genes for 
TLR2, TLR4, and CD14 in the Swiss subpopulation. Geometric means of the expression of 
these genes were significantly higher among farm children than among farm reference 
children (TLR2: 0.74 [95% CI, 0.65-0.84] vs 0.49 [95% CI, 0.43-0.56], P < .0001; TLR4: 
0.98 [95% CI, 0.88-1.09] vs 0.82 [95% CI, 0.72-0.93], P = .034; CD14: 0.48 [95% CI, 0.41-
0.55] vs 0.28 [95% CI, 0.24-0.31], P < .0001), thereby confirming previous data from another 
farming population18. It was, however, not the current exposure to several farm characteristics 
but rather maternal exposure during pregnancy that was associated with increased gene 
expression (Table 2). Likewise, current levels of endotoxin and EPS in mattress dust were not 
correlated with gene expression of their respective receptors (data not shown and Fig E3 in 
the Online Repository at www.jacionline.org). Day-care attendance, reported childhood 
infections, worm infestation, and use of antibiotics or antipyretics during intervening years 
were not associated with gene expression of TLR/CD14 and atopy and did not affect reported 
point estimates. However, a dose-response relation was found when relating the number of 
different farm animal species the mother had contact with during pregnancy to gene 
expression (Figure 2). 
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FIGURE 2. The x-axis shows increasing numbers of different farm animal species the mother had 
contact with during pregnancy (n = 322). The y-axis shows geometric means (dots) of gene expression 
of TLR2, TLR4, and CD14, respectively, which were normalized by dividing by gene expression of 
18s rRNA. In addition, the linear fit of the association (solid line), along with the corresponding 95% 
CI (dashed line), is displayed. All analyses were adjusted for age, sex, family history of atopy, parental 
education, environmental tobacco smoking, maternal smoking during pregnancy, number of older 
siblings, contact with pets ever, child's current exposure to a farming lifestyle, child's exposure to farm 
animals, and predominant farm milk consumption of the child. 
Each additional species of farm animal the mother was exposed to during pregnancy 
increased the expression of TLR2, TLR4, and CD14 by a factor of 1.16 (95% CI, 1.07-1.26), 
1.11 (95% CI, 1.03-1.19), and 1.14 (95% CI, 1.04-1.24), respectively. Neither restricting the 
analysis to farm children only nor omitting the highest category of contact to farm animal 
species during pregnancy materially changed the results. In a model including exposure to 
different animal species during pregnancy and during the first year of life simultaneously, 
stronger effects were observed for exposure during pregnancy (TLR2, 1.11 [95% CI, 1.01-
1.21]; TLR4, 1.05 [95% CI, 0.97-1.14]; CD14, 1.09 [95% CI, 0.99-1.21]) than during the first 
year of life (TLR2, 1.03 [95% CI, 0.94-1.12]; TLR4: 1.02 [95% CI, 0.95-1.10]; CD14: 1.00 
[95% CI, 0.91-1.10]), respectively. The correlation between these 2 variables was moderate (r 
= 0.69). 
TLR2 TLR4 CD14
1.04 (0.69-1.55) 0.93 (0.66-1.3) 1.01 (0.66-1.54)
p= 0.851 p= 0.671 p= 0.964
1.09 (0.75-1.58) 0.92 (0.67-1.25) 0.97 (0.65-1.43)
p= 0.650 p= 0.577 p= 0.866
1.04 (0.77-1.42) 1.06 (0.81-1.4) 1.16 (0.83-1.64)
p= 0.813 p= 0.656 p= 0.385
1.44 (1.04-1.98) 1.4 (1.07-1.83) 1.66 (1.18-2.33)
p= 0.027 p= 0.015 p= 0.003
*!Current regular exposure to stable or barn or regular participation in haying.
†!Mother worked regularly in stable during pregnancy.
TABLE 2. Mutually adjusted geometric means ratios for associations of farm-related 
exposures with the expression of the TLR2, TLR4, and CD14 genes (n = 322) 
Geometric means ratios are given with 95% CIs in parentheses and P values. The models are 
adjusted for age, sex, family history of atopy, parental education, environmental tobacco 
smoking, maternal smoking during pregnancy, number of older siblings, conta
Current farm exposure*
Regular contact to farm 
animals ever
Farm milk consumption 
ever
Stable exposure in 
pregnancy†!
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Discussion 
The present study showed a clear inverse association of a farming environment (farm milk 
consumption, stable/barn visits, and contact with farm animals) with the prevalence of 
seasonal rhinoconjunctivitis, symptoms of seasonal rhinoconjunctivitis, and asthma. Maternal 
exposure to stables in pregnancy was associated with atopic sensitization and the expression 
of genes for receptors of the innate immune system (ie, TLR2, TLR4, and CD14). A dose-
response relation was found between the extent of the upregulation of these genes and the 
number of different farm animal species the mother had contact with during her pregnancy. 
However, only longitudinal studies will eventually establish a causal relationship. 
The identification of farm milk and stable animal contact as being protective for asthma 
and seasonal rhinoconjunctivitis is in accordance with the results of the Allergy and 
Endotoxin study14. The much larger size of the PARSIFAL population allowed, however, a 
more detailed investigation of the relevant time windows of exposure for each outcome. A 
stronger effect of prenatal (ie, maternal) exposure was seen for atopic sensitization. Moreover, 
this effect was observed for gene expression of innate immunity receptors. Stable exposure 
during pregnancy was more relevant than exposure while the mother was breast-feeding, 
thereby shifting the focus to prenatal exposure. The cross-sectional design of the study might 
have resulted in recall bias. However, this is unlikely because the outcomes (IgE levels and 
gene expression) were laboratory parameters not known to the mothers when answering the 
questionnaires. The maternal effect was independent of the mother's history of atopy and 
consistent over geographic areas, with the exception of Sweden. In Sweden none of the 
stables were connected to farmhouses in contrast to the other countries, potentially indicating 
a different pattern and intensity of exposure. Moreover, the levels of microbial compounds in 
house dust differ between Sweden and the other countries16. 
Exposure to farm animals and stables has been found to be associated with increased 
exposure to various microbial products19, 20. TLR2 is a receptor for various microbial 
compounds from gram-positive bacteria and fungi, such as lipopeptides, lipoarabinomannan, 
lipoteichoic acid, and glucans, whereas TLR4 recognizes LPSs mostly from gram-negative 
bacteria. CD14 in turn is involved in the recognition of LPSs and other bacterial wall 
components21. It seems therefore likely that the upregulation of these genes with an increasing 
number of farm animal species the mother was exposed to during pregnancy is attributable to 
increasing levels, diversified levels, or both of microbial exposure associated with contact 
with these animals. 
By recognizing microbial compounds, TLRs are part of innate immunity, the first line of 
defense. The innate immune response communicates with the effector cells of the adaptive 
immune response, which includes the T helper cell populations22. Th1 cells favor the 
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production of IgG antibodies, whereas Th2 cells promote the production of IgE antibodies and 
thereby the development of atopic diseases. In experimental studies it has been shown that 
stimulation of the innate immune response might skew the balance toward antiallergic TH1 
responses23, 24. However, in children of farming environments with high endotoxin exposure, 
a decreased secretion of both Th1 and Th2 cytokines was observed on restimulation of 
leukocytes through the TLR4 ligand LPS25. This finding suggests that mechanisms other than 
a Th1/Th2 imbalance might be operational in these environments. T regulatory cells or 
mechanisms inherent to innate immune signaling, such as LPS tolerance, might play a role18, 
26, 27. 
In the present study current exposures to either stables and barns or to measured levels of 
microbial products indoors were not related to expression of these innate immunity genes. Yet 
other microbial exposures than the ones assessed might have been of greater importance. 
However, endotoxin and EPS are specific ligands for TLR4 and TLR2, respectively21, which 
makes it improbable that we have missed major environmental signals. 
In contrast, maternal contact with increasing numbers of farm animal species, which is 
likely to parallel microbial exposures, was significantly related to a long-lasting upregulation 
of the expression of these innate immunity genes, which was still detectable at school age. 
Similarly, maternal work in stables during pregnancy was associated with decreased 
production of allergen-specific IgE antibodies, which was again detectable at school age. 
Thus prenatal environmental influences might affect the long-term development of innate and 
adaptive immune responses. In turn, the manifestation of organ-specific atopic conditions of 
the upper and lower respiratory tract might depend on the interplay between the growing and 
maturing child and his or her environment. 
It is unknown how the maternal environment exerts its effect on the offspring. One might 
speculate that the fetal immune system interacts with a certain cytokine pattern prevailing in 
the maternal organism28 or with the antigens themselves29, implying the establishment of 
immunologic tolerance. Another attracting explanation might consist in epigenetic 
inheritance. Differential patterns of gene expression arise during development in utero and are 
subsequently retained through mitosis. Stable alterations are heritable but do not involve 
mutations of the DNA itself30, 31. Recent data suggest that environmental factors might alter 
methylation processes, a key element of epigenetic inheritance30. Furthermore, there is some 
evidence suggesting that endotoxin has a role in gene silencing because LPS is a potent 
inflammogen that stimulates acetylation of histones32. 
The PARSIFAL study does not provide information on the maternal exposure before 
pregnancy, and therefore we cannot exclude a preconceptional effect. In other words, the 
mother's earlier exposure to a farming environment might have determined a configuration of 
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her immune system, which she then passed on to her child. If indeed preconceptional 
exposures were important, environmental determinants of disease inception would also 
operate in the parental generation. Recent observations demonstrating a plateau of the 
prevalences of asthma, seasonal rhinoconjunctivitis, and atopic sensitization after 3 decades33-
35, which approximates a generation, might indirectly support the notion of a generational 
effect. Furthermore, a transgenerational association of a grandmother's smoking with her 
grandchildren's risk for asthma has recently been reported36. Of note, in our rural population 
the effect of maternal work in stables during pregnancy on the child's atopy risk was 
independent from the mother's smoking habits. The lack of insight into the determinants of 
the increase in the prevalence of asthma and allergies over time might therefore in part be 
explained by the neglect of the potential effect of preconceptional exposures of the parents. 
In conclusion, our results suggest that maternal exposures to environments rich in 
microbial exposures determine the priming of a child's immune response. For organ-specific 
manifestation of allergic diseases, additional factors, continuing exposure, or both effective 
later in life seem to be important. Our findings stress the importance of the identification of 
the appropriate time window leading to the modulation of immune responses and disease 
manifestation, respectively. Longitudinal studies will eventually deepen our understanding of 
the relevant temporal sequences. 
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Abstract 
Prenatal exposure to microbial components is associated with protection against allergies 
in school age children. Furthermore, it prevents subsequent allergen-induced sensitization and 
airway inflammation in mice and it induces the expression of Toll-like receptor genes, the 
principal pattern recognition receptors of the innate immune system. How long the changes in 
the innate immune system persist after exposure to microbes in early life is unknown. In this 
study, we assessed that a single challenge of newborn mice with a mixture of S.aureus and 
E.coli was able to enhance the gene expression of marker genes of the innate immune system 
persistently over three months without induction of chronic inflammation. These results 
indicate that the innate immune system may have a memory-like character. 
Introduction 
The innate immune system is an evolutionary conserved system controlling infections in an 
early phase. Vertebrates improved the immune response by evolving the more effective 
adaptive immunity consisting of an enormously diverse antigen-recognizing lymphocytes 
pool1. After infection lymphocytes, bearing receptors able to bind antigens, start to clonally 
expand and to undergo hypermutations and affinity maturation. With the end of the infection, 
most of the antigen-specific lymphocytes die but the adaptive immunity maintains the 
knowledge how to fight the infection through the generation of antigen-experienced memory 
cells. This pool of long-lived memory cells is continuously growing and guarantees a more 
rapid and robust response to subsequent encountering of a previously experienced antigen2. 
The innate immune system is generally characterized by missing memory. It recognizes 
conserved foreign patterns by germ-line encoded receptors. Toll-like receptors (TLR) 
constitute the principal family of these receptors3. Ligand binding to TLR triggers a tightly 
regulated signaling cascade inducing defence mechanisms, co-stimulatory molecules, and 
cytokines necessary for activation of the adaptive immunity4, 5. Recent studies showed that the 
human innate immune systems adapts to exposure to foreign structures, too. Expression of 
TLR and of regulatory molecules like suppressor of cytokine signaling (SOCS)-1 were 
induced by environmental exposure to microbial components6. Especially prenatal or neonatal 
exposure of children seems to shape the innate immune system7. These modulations are 
associated with reduced inflammatory responses and protection against allergy and 
autoimmunity8, 9. 
In this study we were interested whether the innate immune system has memory-like 
character, too. We investigated whether singular application of microbial components to 
newborn mice establishes persistent memory in the innate immune system. Our mouse model 
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showed that expressions of TLR genes, of genes of TLR signaling cascade, and of genes of 
molecules inducing T cell independent immunoglobulin isotype switching were elevated three 
months after application of microbial components. These enhanced modulations were not 
based on chronic inflammation. 
Methods 
Mice. We purchased pregnant C57BL/6 mice (Harlan) and kept them under optimal 
husbandry conditions. Two, four, and six days after birth, we injected the newborn mice 
subcutaneously in the neck either with 30µl of a 0.9% NaCl solution, 30µl of a heat-killed 
(60°C, 1 hour) mixture of 50 thousand Staphylococcus aureus (S. aureus) and 50 thousand 
Escherichia coli (E. coli) bacteria, or 30µl of a 1:1 dilution of complete Freund’s adjuvant 
(CFA; Sigma) using a BD Micro-Fine Insulin syringe (0.5ml, 0.30mm (30G) x 8mm; BD 
biosciences). Three months after the last injection, we obtained blood plasma and lymph 
nodes (superficial cervivals, axillary, and brachial). We added 500µl RNAlater (Ambion) 
solution to lymph nodes, shock-froze them in liquid nitrogen, and stored them at minus 80°C. 
We took full blood with a syringe out of the heart after opening the thorax and protected it 
against coagluation with 100µl heparin. The plasma was separated by centrifugation. 
Tissues homogenization and RNA extraction. We transferred 30mg of the thawed lymph 
nodes to RLT buffer (QIAmp RNA Blood Mini Kit, Qiagen) supplemented with 1% β-
mercaptoethanol and homogenized it using a Retsch MM300 mixer mill (Retsch). For total 
RNA extraction, we used the QIAmp RNA Blood Mini Kit (Qiagen) supplemented with 
RNase-free DNase (Qiagen). 
RT-PCR and quantitative real-time PCR. For reverse transcription (RT) of RNA we 
used 300ng of total RNA in a final volume of 30µl and added adequate amounts of TaqMan® 
Reverse Transcription Reagents (Applied Biosystems). Quantitative real-time PCR was 
performed in an ABI Prism 7900 Sequence Detection SystemTM (Applied Biosystems) using 
the TaqMan® low density array system of Applied Biosystems. 18S rRNA, glucuronidase beta 
(GUS), and beta-2-microglobulin (B2M) acted as endogenous controls. To each fill port we 
added 100µl of a mixture of cDNA (100ng) and TaqMan Universal PCR Master MixTM 
(Applied Biosystems). The determined gene expression values were normalized to the 
geometric mean of the parallel measured endogenous controls 18S rRNA, GUS, and B2M10. 
We analyzed the data with the comparative Ct method according to the manufacturer’s 
instructions (Applied Biosystem). 
Immunoglobulin quantification. We determined levels immunoglobulin isotypes in 
untreated plasma samples of mice using the Beadlyte mouse immunoglobulin isotyping kit 
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(Upstate) and analyzed it with a Luminex instrument (Luminex Technology). The amount of 
immunoglobulin was related to the total amount of protein in the plasma measured with a 
BCATM  protein assay kit (Pierce). 
Results 
To assess a memory of the innate immune system we challenged newborn mice with a 
cocktail of heat-killed S.aureus and E.coli bacteria. Furthermore, we stimulated newborn mice 
with complete Freund’s adjuvant (CFA). This mixture of mycobacteria and mineral oil is 
known to have long-term immuno-stimulatory effects11. Three months after application, we 
determined the expression of TLR genes and of genes of the TLR signaling cascade in lymph 
nodes situated near the application area by quantitative real-time PCR (Figure 1). We were 
able to detect significant up-regulation of TLR2, TLR3, and TLR4, and of the signaling 
molecule MyD88 through application of the E.coli/S.aureus mixture, while CFA failed to 
induce marker genes of the innate immune system. Furthermore, a slight induction of CD14 
and IRAK-4 expression was observed but the expression of TLR5, TLR7, TLR9, and of other 
genes of signaling molecule failed to alter (data not shown). 
 
FIGURE 1. Expression of maker genes of the innate immune system in mice three months after 
challenging them with bacterial components. We compared expression of TLR genes (a-c), of CD14 
gene (d), and of genes of TLR signaling cascade (e, f) in lymph nodes of mice treated with a mixture 
of S. aureus and E.coli (grey bars) or with CFA (black bars) three months ago. Control mice were 
treated with NaCl solution (white bars). All expression values were normalized to the geomean of 
three endogenous controls. Bars represent the mean of 8 mice; error bars are standard errors of the 
mean; * = p < 0.05, + = p < 0.1. 
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Next, we were interested whether application of bacterial components had also long-term 
consequences on the function of the innate immune system. Since a principal function of the 
innate immune system is to release cytokines, we measured the expression of cytokine genes 
in lymph nodes of stimulated mice by quantitative real-time PCR (Figure 2). The expression 
of TNF gene and to a minor extant the expression of interleukin (IL)-6 gene were still 
elevated three months after application of S.aureus and E.coli, while CFA had no effects. 
Furthermore, the gene expression of IL-12, gamma interferon (IFN-γ), IL-13, IL-10, and 
TGF-β was unaffected (data not shown). 
 
FIGURE 2. Expression of TNF and IL-6 in mice stimulated with bacterial components three months 
ago. We compared the gene expression of TNF (a) and IL-6 (b) in lymph nodes of mice three month 
after they were challenged with a mixture of S. aureus and E.coli (grey bars), with CFA (black bars), 
or with NaCl (control, white bars). All expression values were normalized to the geomean of three 
endogenous controls. Bars represent the mean of 8 mice; error bars are standard errors of the mean; * 
= p < 0.05, + = p < 0.1. 
Another function of the innate immune system is to direct T helper cell differentiation. To 
assess whether mice challenged with bacterial components had altered T helper cell 
differentiation, we measured the expression of T helper cell marker genes in lymph nodes by 
quantitative real-time PCR (Figure 3). S.aureau and E.coli enhanced the expression of the T 
helper cell type (Th)-1 marker T-bet of borderline significance. The expression of the Th-2 
marker GATA-3 and of FOXP3, a marker for T regulatory (Treg) cells, was slightly increased 
but non-significant. CFA failed to alter the expression of T cell markers. 
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FIGURE 3. Expression of T helper cell and T regulatory cell marker in mice stimulated with bacterial 
components three months ago. We compared the expression of T-bet (a), GATA-3 (b), and FOXP3 (c) 
gene in lymph nodes of mice stimulated with a mixture of S. aureus and E.coli (grey bars), with CFA 
(black bars), or with NaCl (control, white bars) three months ago. All expression values were 
normalized to the geomean of three endogenous controls. Bars represent the mean of 8 mice; error 
bars are standard errors of the mean; * = p < 0.05, + = p < 0.1. 
Innate immunity has the potential to induce T cell independent immunoglobulin isotype 
switching via release of BAFF (B lymphocyte stimulator protein) and APRIL (a proliferation-
inducing ligand). BAFF and APRIL bind B cells directly. We assessed the expression of 
BAFF and APRIL genes by quantitative real-time PCR in lymph nodes of mice treated three 
months ago with bacterial components (Figure 4). We found that S.aureus and E.coli induced 
the expression of the BAFF gene and also of the APRIL gene but less significant. By contrast, 
expression of CD40 ligand, a marker for T cell dependent immunoglobulin isotype switching, 
was unaltered. CFA failed to induce expression of any of these molecules.  
 
FIGURE 4. Expression of ligands inducing T cell independent or T cell dependent immunoglobulin 
isotype switching in mice stimulated with bacterial components three months ago. We challenged 
newborn mice with a mixture of S. aureus and E.coli (grey bars), with CFA (black bars), or with NaCl 
(control, white bars) and compared the expression of the APRIL (a), BAFF (b), and CD40 ligand (c) 
gene in lymph nodes three months later. All expression values were normalized to the geomean of 
three endogenous controls. Bars represent the mean of 8 mice; error bars are standard errors of the 
mean; * = p < 0.05, + = p < 0.1. 
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Chonic inflammation could be the cause for enhanced activiation of the innate immune 
system and thereby alter the expression of genes. Because S.aureus and E.coli enhanced 
expression of many genes of the innate immune system, we were interested whether 
application of bacterial components induced chronic inflammation. To investigate this, we 
measured immunoglobulin levels in blood plasma of mice as marker for systemic 
inflammation using Luminex technology (Figure 5). S.aureus and E.coli application failed to 
enhance immunoglobulin secretion, while CFA enhanced immunoglobulin levels of all 
assessed isotypes.  
 
FIGURE 5. Comparison of immunoglobulin levels in blood plasma of mice treated with bacterial 
components three months ago. We applied a mixture of S. aureus and E.coli (grey bars), CFA (black 
bars), or NaCl (control, white bars) to newborn mice and assessed immunoglobulin levels in blood 
plasma three months later. All immunoglobulin levels are expressed as percentage of total protein in 
the blood plasma. Bars represent the mean of 8 mice; error bars are standard errors of the mean. 
Discussion 
Three things feature the memory of the adaptive immune system. It is generated through 
encountering of foreign antigens, it is long lived, and it has functional consequences achieved 
by faster cell proliferation and enhanced secretion of immunoglobulin via subsequent 
encountering of a previously experienced antigen. Our study indicates a memory of the innate 
immune system, too. We observed that single encountering of microbial components shapes 
the innate immune system in a persistent way as observed by elevated expression of various 
marker molecules. Remarkable, these modulations were not induced due to chronic 
inflammation. By contrast, CFA inducing a broad chronic inflammation failed to have 
persistent effects on innate immunity. 
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The concept of our study failed to answer whether these modulations have functional 
consequences. Our data indicate a slight shift towards Th-1 differentiation and enhanced T 
helper cell independent immunoglobulin isotype switching shown by increased expression of 
BAFF and APRIL. Data of epidemiologic and animal studies indicate that modulations 
having similar character to the ones we observed in our study, have the potential to protect 
against inflammatory, allergic, and autoimmune diseases5-7, 9, 12, 13. Therefore, we propose that 
the innate immune system has a memory function. 
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An allergic immune response is an inappropriate or an overreaction of the immune system 
against harmless pathogens. Besides genetic predisposition, environmental exposure to 
various factors such as microbes, allergens, air pollution, or dietary factors influence the 
development of allergies1. A very illustrative example, how genetic predisposition and 
environmental factors collude, was the CD14 polymorphism (CD14/-1721). Consuming non-
pasteurized milk protected only children carrying the AA and less extended the AG allele 
against allergic disorders. Furthermore, the AA and the AG allele correlated with enhanced 
CD14 gene expression due to non-pasteurized milk consumption (Bieli et al., submitted). 
The hygiene hypothesis has been postulated as an explanation for the increased prevalence 
of allergic disorders in Western society1. In this work, we investigated how environmental 
factors influence the immune system in context of the development of allergic diseases. We 
used farmers’ children as model because rural lifestyle turned out to be highly protective2-4. 
The innate immune system constitutes the first contact to invading microbes and drives the 
adaptive immune response by T helper cell activation. Therefore, it has been proposed that the 
innate immune system has a crucial role in protecting against the development of allergies5. 
Support came from results that TLR gene expression was induced in farmers’ children and 
several polymorphisms in genes of the innate immunity associated with allergic diseases1, 6-10. 
The widespread immunological basis of the hygiene hypothesis is that reduced microbial 
stimulation of TLR of innate immune cells in early life leads to a shift towards Th-2 responses 
against allergens11. Besides of epidemiological data describing an increase of Th-1 and Th-2 
associated disease in Western society12, our gene expression measurements failed to show an 
enhanced Th-1 response in farmers’ children. Furthermore, the recently postulated Treg cells 
were not enhanced in these children. Therefore, reduced hygiene conditions of a farm failed to 
influence T cell differentiation and they do not constitute the immunological basis of the 
hygiene hypothesis. 
All T helper cell phenotypes were associated with immunoglobulin class switching to IgE 
in children. Therefore, elevated T helper cell levels, probably generated by genetic 
predisposition or by unknown environmental conditions, enhance immunoglobulin CSR to 
IgE and seem thereby to support the development of allergies. Skewing of the T helper cell 
balance may only become important if microbial levels are much higher, as it is the case 
during an infection. 
An innate immune system, shaped by reduced hygienic conditions of a farm, is able to 
decrease the risk to develop allergies through reduction of inflammatory responses and of 
immunoglobulin CSR to IgE. Regulation of the innate immune system has to be very tight. 
Insufficient activation leads to inefficient defence against an infection, over-activation may 
lead to chronic inflammation, allergy, and autoimmunity. In our epidemiological studies, we 
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observed that expression of the regulatory molecule of the TLR signaling cascade SOCS-1 
was influenced by exposure to environmental microbial components. Enhanced expression of 
these molecules shift the innate immune system into a status of tolerance meaning that it 
exhibits decreased inflammatory responses to further applications of microbial components. 
But not all of these regulatory molecules seem to have the same relevance in induction of 
tolerance mediated by exposure to environmental microbes in children. We failed to 
reproduce this function for ST2. ST2 is up-regulated shortly after administration of bacterial 
components and may regulate TLR signaling cascade in an early phase13, 14. Chronic exposure 
to microbes, as it was the case for the children of our study, reduced the ST2 expression. This, 
in turn, was associated with reduced non-phenotype specific T helper cell activation and 
reduced incidence of allergies. Therefore, ST2 may exhibit its protective function against 
allergies via regulating T helper cell activity, which we showed to be crucial in inducing 
immunoglobulin CSR to IgE. 
Children, exposed to microbes in the environment, build up a network of molecules 
desensitizing the innate immune system against harmless antigens or antigens in low-dose. 
This network has the potential to inhibit an inappropriate adaptive immune response, as it is 
the case in allergic disorders. The expression of SOCS-1 correlates with reduced IgE levels in 
serum and expression of TLR and BAFF negatively associates with immunoglobulin CSR to 
IgE. The expression of these molecules, in turn, is enhanced via exposure to environmental 
microbes. Whether these immunological mechanisms are linked together or whether there are 
other regulatory molecules involved, for example the MHC class II molecule, which we 
described to have regulatory functions in the innate immune system, is going to be the subject 
of further data analysis. To assess the complexity of the complete regulatory network of the 
innate immune system, alternative methods for data analysis may be used. Biclustering15, 16, 
chaos theory, or dynamic models are a few examples. Furthermore, it would be interesting to 
investigate whether an innate immune system shaped via exposure to environmental microbes 
protects against the development of autoimmune diseases, too. Especially, the pattern of 
natural antibodies may be influenced via exposure to different environmental conditions. 
Natural antibodies are germ-line encoded antibodies binding almost exclusive self molecules. 
Although the function of natural antibodies is not clear, specific self molecules recognized by 
these autoantibodies appear to form clinically defining patterns heralding for example 
autoimmune diseases17. 
Epidemiological studies are a useful tool to investigate immunity in context of 
environmental conditions because these conditions can hardly be simulated in the lab. The 
option to check the relevance of mechanisms discovered in vitro or with mouse models in 
real-life conditions is the main advantage of such systems. Not all results achieved by lab 
conditions have relevance in normal life as our results of the Th-1/Th-2 balance showed. 
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Drawbacks of epidemiological studies are the impreciseness in questionnaires and the 
immense time and effort. To assess significant correlations between parameters, generally 
huge numbers of samples are necessary to exclude interfering effects. Nevertheless, this work 
shows that strong and promising correlations can be found in small populations. 
How long children have to live in a rural environment until protection against the 
development of allergic disorders establishes was another aspect, we investigated in this 
work. Children of the PARSIFAL study were highly protected if their mother had contact to 
stable or stable animals during pregnancy7. Furthermore, we achieved persistent elevation of 
the expression of marker genes of the innate immune system via single administration of 
microbial components in early life of mice and thereby protected them against the 
development of allergies18. Therefore, it seems that prenatal or early life exposure to microbes 
is crucial to induce a memory-like function of the innate immune system that may be able to 
protect against allergies. Interesting new insights in this field is going to give us the 
PASTURE (Protection against Allergy: Study in Rural Environments) study. For this 
longitudinal epidemiological study, pregnant woman living on farms were recruited. Newborn 
children spend blood at their birth (cord blood), at the age of one, and at the age of 5 years. 
Therefore, we are able to observe the development of protective mechanisms through 
exposure to environmental microbial components over time. Furthermore, we are going to 
investigate whether long-term modulations of innate immune system are based on antigen-
persistence in the body as it is proposed for the memory of the adaptive immunity or due to 
changes in cytosine methylation patterns of gene promoters19, 20. Cytosine methylation within 
CpG dinucleotides of DNA acts in concert with other chromatin modifications to maintain 
specific genomic regions in a transcriptional silent state. 
Our data support the idea of a vaccination-like therapeutic challenge of the innate immune 
system. Currently, promising clinical studies with probiotic microbes are ongoing. Prenatal 
administration of probiotic microbes to children had preventive effects on atopic diseases at 
least until the age of 4 years. Probiotic microbes are live microorganisms culturing the gut and 
thereby providing a beneficial stimulus to the innate immune system. Interestingly, porbiotic 
microbes failed to reduce antigen-specific IgE antibodies21. Challenging the innate immunity 
of mice by TLR agonists provided interesting results, too. Application of TLR2, TLR4, and 
TLR9 ligands reduced the degree of allergic asthma through reduction of inflammation, total 
serum IgE and number of T helper cells in the lung1, 18, 22. Another promising therapeutic 
target in the prevention of allergic disorders is the use of non-pathological helminth parasites, 
since they have high protective effects although they induce a large Th-2 response. The 
results of the currently running epidemiological studies are going to show whether helminth 
eggs are useful as vaccination against allergic disorders. It would be interesting to investigate 
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whether these therapeutic tools have beneficial effects on the regulatory network of the innate 
immunity. 
References 
1. Vandenbulcke, L., Bachert, C., Van Cauwenberge, P. & Claeys, S. The innate immune 
system and its role in allergic disorders. Int Arch Allergy Immunol 139, 159-65 
(2006). 
2. Braun-Fahrlander, C. et al. Prevalence of hay fever and allergic sensitization in 
farmer's children and their peers living in the same rural community. SCARPOL team. 
Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air 
Pollution. Clin Exp Allergy 29, 28-34 (1999). 
3. Von Ehrenstein, O. S. et al. Reduced risk of hay fever and asthma among children of 
farmers. Clin Exp Allergy 30, 187-93 (2000). 
4. Riedler, J., Eder, W., Oberfeld, G. & Schreuer, M. Austrian children living on a farm 
have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 30, 194-200 
(2000). 
5. Medzhitov, R. Toll-like receptors and innate immunity. Nat Rev Immunol 1, 135-45 
(2001). 
6. Lauener, R. P. et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-
farmers' children. Lancet 360, 465-6 (2002). 
7. Ege, M. J. et al. Prenatal farm exposure is related to the expression of receptors of the 
innate immunity and to atopic sensitization in school-age children. J Allergy Clin 
Immunol 117, 817-23 (2006). 
8. Baldini, M. et al. A Polymorphism* in the 5' flanking region of the CD14 gene is 
associated with circulating soluble CD14 levels and with total serum immunoglobulin 
E. Am J Respir Cell Mol Biol 20, 976-83 (1999). 
9. Eder, W. et al. Toll-like receptor 2 as a major gene for asthma in children of European 
farmers. J Allergy Clin Immunol 113, 482-8 (2004). 
10. Arbour, N. C. et al. TLR4 mutations are associated with endotoxin 
hyporesponsiveness in humans. Nat Genet 25, 187-91 (2000). 
 110 
11. Romagnani, S. Immunologic influences on allergy and the TH1/TH2 balance. J 
Allergy Clin Immunol 113, 395-400 (2004). 
12. Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic 
diseases. N Engl J Med 347, 911-20 (2002). 
13. Brint, E. K. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 
signaling and maintains endotoxin tolerance. Nat Immunol 5, 373-9 (2004). 
14. Saccani, S., Polentarutti, N., Penton-Rol, G., Sims, J. E. & Mantovani, A. Divergent 
effects of LPS on expression of IL-1 receptor family members in mononuclear 
phagocytes in vitro and in vivo. Cytokine 10, 773-80 (1998). 
15. Barkow, S., Bleuler, S., Prelic, A., Zimmermann, P. & Zitzler, E. BicAT: a 
biclustering analysis toolbox. Bioinformatics 22, 1282-3 (2006). 
16. Prelic, A. et al. A systematic comparison and evaluation of biclustering methods for 
gene expression data. Bioinformatics 22, 1122-9 (2006). 
17. Merbl, Y. et al. Newborn humans manifest autoantibodies to defined self molecules 
detected by antigen microarray informatics. The J Clin Invest 117:712-718 (2007). 
18. Gerhold, K. et al. Prenatal initiation of endotoxin airway exposure prevents subsequent 
allergen-induced sensitization and airway inflammation in mice. J Allergy Clin 
Immunol 118, 666-73 (2006). 
19. Zinkernagel, R. M. Maternal antibodies, childhood infections, and autoimmune 
diseases. N Engl J Med 345, 1331-5 (2001). 
20. Vercelli, D. Genetics, epigenetics, and the environment: switching, buffering, 
releasing. J Allergy Clin Immunol 113, 381-6; quiz 387 (2004). 
21. Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H. & Isolauri, E. Probiotics and 
prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled 
trial. Lancet 361, 1869-71 (2003). 
22. Velasco, G. et al. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. 
Am J Respir Cell Mol Biol 32, 218-24 (2005). 
 
 111 
Abbreviations 
AICDA activation-induced cytidine deaminase 
ALEX Allergy and Endotoxin 
APC antigen-presenting cells 
APRIL a proliferation-inducing ligand 
BAFF/BLyS B lymphocyte stimulator protein  
BAFF-R/BR3 BAFF receptor 
BCL B cell lymphoma 
BCMA B cell maturation antigen 
BLP bacterial lipoprotein 
CIITA class II transactivator 
CARD caspase activation and recruitment domain 
CD40L CD40 ligand 
CFA complete Freund’s adjuvant 
CSR class-switch recombination 
CTL cytotoxic T lymphocyte 
CTLA cytotoxic T lymphocyte antigen 
DC dendritic cells 
ERK extracellular-signal-regulated kinase 
EU endotoxin units 
FADD Fas-associated via death domain 
GLT germ-line transcript 
hBD human β-defensin 
HEK human embryonic kidney 
ID inhibitor of DNA binding 
Ig immunoglobulin 
IKK IκB kinase 
IL interleukin 
 112 
INF interferon 
IRAK IL-1R-associated kinase 
IRF interferon regulatory factor 
ITAM immunoreceptor tyrosine-based activation motif 
JNK Jun N-terminal kinase 
ko knock-out 
LPS lipopolysaccharides 
LRR leucin-rich repeats 
Mda melanoma differentiation associated gene 
MCD methyl-β-cyclodextrin 
MHC major histocompatibility complex 
MyD88 myeloid differentiation primary-response protein 88 
NOD nucleotide-binding oligomerization domain 
PAMP pathogen-associated molecular pattern 
PARSIFAL Prevention of Allergy Risk factors for Sensitization In children related 
to Farming and Anthroposophic Lifestyle 
PASTURE Protection against Allergy: Study in Rural Environments 
PBL peripheral blood leukocytes 
PI3K phosphatidylinositol 3-kinase 
PKR dsRNA-dependent protein kinase 
PRR pattern recognition receptors 
RAG recombination-activating genes 
RIG retinoic-acid-inducible protein 
RIP receptor-interacting protein 
RSS recognition signal sequences 
SARM steril α and armadillo motifs 
SOCS suppressor of cytokine signaling 
STAT signal transducer and activator of transcription 
TAB TAK1 binding proteins 
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TACI transmembrane activator and calcium modulator and cyclophylin 
ligand interactor 
TAK TGF-β-activated kinase 
TCR T cell receptor 
Th T helper cell 
TIR Toll/IL-1R homology 
TIRAP/MAL TIR-associated protein 
TLR Toll-like receptors 
TNF tumor necrosis factor 
TOLLIP Toll-interacting protein 
TRAF TNFR-associated factor 
TRAM TRIF-related adaptor molecule 
Treg T regulatory cell 
TREM triggering receptors expressed by myeloid cells 
TRIF/TICAM1 TIR-domain-containing adaptor protein-inducing IFN-β 
wt wild type 
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